• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 6-K filed by Ambev S.A.

    8/1/25 5:01:23 PM ET
    $ABEV
    Beverages (Production/Distribution)
    Consumer Staples
    Get the next $ABEV alert in real time by email
    6-K 1 abevitr2q25_6k.htm 6-K

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     


     

    FORM 6-K

     

    Report of Foreign Private Issuer
    Pursuant to Rule 13a-16 or 15d-16 of the

    Securities Exchange Act of 1934

     

    For the month of Augut, 2025

    Commission File Number 1565025

     


     

    AMBEV S.A.

    (Exact name of registrant as specified in its charter)

     

    AMBEV S.A.

    (Translation of Registrant's name into English)

     

    Rua Dr. Renato Paes de Barros, 1017 - 3rd Floor
    04530-000 São Paulo, SP
    Federative Republic of Brazil

    (Address of principal executive office)

     

    Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F. 


    Form 20-F ___X___ Form 40-F _______

     Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.  

    Yes _______ No ___X____

     
     

    Ambev S.A.

    Interim consolidated
    financial statements at
    June 30, 2025
    and report on review

     
     

    Report on review interim

    consolidated financial statements

     

     

    To the Board of Directors and Shareholders

    Ambev S.A.

     

     

     

    Introduction

     

    We have reviewed the accompanying interim consolidated balance sheet of Ambev S.A. and its subsidiaries ("Company") as at June 30, 2025, the related interim consolidated income statement and statement of comprehensive income for the quarter and six-month periods then ended and the related interim consolidated statements of changes in equity and cash flows for the six-month period then ended, and notes, comprising a summary of material accounting policies and other explanatory information.

     

    Management is responsible for the preparation and fair presentation of these interim consolidated financial statements in accordance with the accounting standard International Accounting Standard (IAS) 34 - Interim Financial Reporting, of the International Accounting Standards Board (IASB). Our responsibility is to express a conclusion on these interim consolidated financial statements based on our review.

     

    Scope of review

     

    We conducted our review in accordance with International Standards on Reviews of Interim Financial Information (ISRE 2410 - Review of Interim Financial Information Performed by the Independent Auditor of the Entity, respectively). A review of interim information consists of making inquiries, primarily of people responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with Brazilian and International Standards on Auditing and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion.

     

    Conclusion

     

    Based on our review, nothing has come to our attention that causes us to believe that the accompanying interim consolidated financial statements referred to above are not prepared, in all material respects, in accordance with IAS 34.

     

    São Paulo, August 1, 2025

     

     

     

     

    PricewaterhouseCoopers

    Auditores Independentes Ltda.

    CRC 2SP000160/O-5

     

    Sergio Eduardo Zamora

    Contador CRC 1SP168728/O-4

     

     

    www.pwc.com.br

    PricewaterhouseCoopers Auditores Independentes Ltda.
    Avenida Brigadeiro Faria Lima, 3732, Edifício B32, 16o,
    São Paulo, SP, Brasil, 04538-132

    T: +55 (11) 4004-8000

      

     
     

     

    Contents

    INTERIM CONSOLIDATED BALANCE SHEET 2
    INTERIM CONSOLIDATED INCOME STATEMENT 4
    INTERIM CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME 5
    INTERIM CONSOLIDATED STATEMENT OF CHANGES IN EQUITY 6
    INTERIM CONSOLIDATED STATEMENT OF CASH FLOWS 8
    1.   CORPORATE INFORMATION 9
    2.   BASIS OF PREPARATION AND PRESENTATION OF THE INTERIM CONSOLIDATED FINANCIAL STATEMENTS 10
    3.   SUMMARY OF MATERIAL ACCOUNTING POLICIES 12
    4.   USE OF ESTIMATES AND JUDGMENTS 13
    5.   CASH AND CASH EQUIVALENTS AND INVESTMENT SECURITIES 13
    6.   INVENTORIES 14
    7.   RECOVERABLE TAXES 14
    8.   ASSETS AND LIABILITIES HELD FOR SALE 15
    9.   INCOME TAX AND SOCIAL CONTRIBUTION 16
    10.   PROPERTY, PLANT AND EQUIPMENT 18
    11.   GOODWILL 21
    12.   TRADE PAYABLES 21
    13.   INTEREST-BEARING LOANS AND BORROWING 22
    14.   PROVISIONS, CONTINGENT LIABILITIES AND CONTINGENT ASSETS 22
    15.   CHANGES IN EQUITY 26
    16.   SEGMENT REPORTING 30
    17.   NET SALES 34
    18.   OTHER OPERATING INCOME/(EXPENSES) 34
    19.   EXCEPTIONAL ITEMS 34
    20.   FINANCIAL RESULTS 35
    21.   SHARE-BASED PAYMENTS 35
    22.   FINANCIAL INSTRUMENTS AND RISKS 37
    23.   COLLATERAL AND CONTRACTUAL COMMITMENTS TO SUPPLIERS, ADVANCES FROM CUSTOMERS AND OTHERS 45
    24.   RELATED PARTIES 46
    25.   EVENTS AFTER THE REPORTING PERIOD 48

     

     

    AMBEV S.A.

     

    INTERIM CONSOLIDATED BALANCE SHEET

    All amounts in thousands of Brazilian Reais

     

    Assets Note 06/30/2025 12/31/2024
           
    Cash and cash equivalents 5.1 16,404,025  28,595,666 
    Investment securities 5.2 1,120,553  1,242,001 
    Trade receivables   5,086,848  6,269,863 
    Derivative financial instruments 22 261,499  1,218,561 
    Inventories 6 11,351,630  11,689,767 
    Recoverable taxes 7 3,736,529  3,582,275 
    Other assets   2,139,181  1,557,651 
    Assets held for sale 8 691,691  -   
    Current assets   40,791,956  54,155,784 
           
    Investment securities 5.2 103,503  184,454 
    Derivative financial instruments 22 4,849  26 
    Recoverable taxes 7 10,065,448  10,503,977 
    Deferred tax assets 9.1 8,882,165  8,691,670 
    Other assets   1,405,482  1,462,588 
    Employee benefits   27,896  70,483 
    Long term assets   20,489,343  20,913,198 
           
    Investments in associates and joint ventures   359,104  395,393 
    Property, plant and equipment 10 27,478,831  30,170,194 
    Intangible assets   11,357,982  12,530,712 
    Goodwill 11 41,680,327  44,342,668 
           
    Non-current assets   101,365,587  108,352,165 
           
    Total assets   142,157,543  162,507,949 

     

    The accompanying notes are an integral part of these interim consolidated financial statements.

     

    AMBEV S.A.

     

    INTERIM CONSOLIDATED BALANCE SHEET (CONTINUED)

    All amounts in thousands of Brazilian Reais

     

    Equity and liabilities Note 06/30/2025 12/31/2024
           
    Trade payables 12 19,883,312  25,223,522 
    Derivative financial instruments 22 920,976  204,721 
    Interest-bearing loans and borrowing 13 1,100,578  1,276,391 
    Payroll and social security payables   2,136,546  2,779,753 
    Dividends and interest on capital payables   3,812,983  8,487,242 
    Income tax and social contribution payable   1,659,396  1,941,540 
    Taxes and contributions payable   3,543,821  5,648,399 
    Other liabilities, including put options granted on subsidiaries   3,142,958  3,386,235 
    Provisions 14 536,413  440,911 
    Liabilities associated with assets held for sale 8 135,256  -   
    Current liabilities   36,872,239  49,388,714 
           
    Trade payables 12 320,323  327,706 
    Derivative financial instruments 22 9,767  6,720 
    Interest-bearing loans and borrowing 13 2,057,186  2,176,337 
    Deferred tax liabilities 9.1 4,219,505  5,007,711 
    Income tax and social contribution payable   1,199,028  1,372,387 
    Taxes and contributions payable   631,251  597,449 
    Other liabilities, including put options granted on subsidiaries   1,142,533  1,142,775 
    Provisions 14 478,646  670,904 
    Employee benefits   2,016,108  2,236,732 
    Non-current liabilities   12,074,347  13,538,721 
           
    Total liabilities   48,946,586  62,927,435 
           
    Equity 15    
    Issued capital   58,275,696  58,226,036 
    Reserves   106,808,173  108,973,429 
    Carrying value adjustments   (76,937,052) (68,557,326)
    Retained earnings/(losses)   4,324,819  -   
    Equity attributable to Ambev’s shareholders   92,471,636  98,642,139 
    Non-controlling interest   739,321  938,375 
    Total equity   93,210,957  99,580,514 
           
    Total equity and liabilities   142,157,543  162,507,949 

     

     

     

    The accompanying notes are an integral part of these interim consolidated financial statements.

     

     

    AMBEV S.A.

     

    INTERIM CONSOLIDATED INCOME STATEMENT

    For the Six and three-month periods ended June 30

    All amounts in thousands of Brazilian Reais unless otherwise stated

     

        six-month period ended:   Three-month period ended:
      Note 2025 2024   2025 2024
                 
    Net sales 17 42,587,572  40,320,512    20,090,194  20,044,215 
    Cost of sales   (20,991,855) (20,118,974)   (10,046,123) (10,059,980)
    Gross profit   21,595,717  20,201,538    10,044,071  9,984,235 
                 
    Distribution expenses   (5,457,042) (5,441,488)   (2,580,347) (2,750,478)
    Commercial expenses   (4,242,833) (4,095,671)   (2,172,906) (2,211,147)
    Administrative expenses   (2,915,194) (2,783,398)   (1,426,347) (1,451,030)
    Other operating income/(expenses) 18 1,201,053  1,112,613    585,855  519,584 
    Exceptional items 19 (72,575) (29,296)   (51,208) (11,727)
    Income from operations   10,109,126  8,964,298    4,399,118  4,079,437 
                 
    Finance income 20 1,344,113  1,130,481    660,565  530,731 
    Finance expenses 20 (2,132,867) (1,917,545)   (1,078,665) (905,076)
    Other net financial results 20 (1,041,613) (235,103)   (555,885) (241,878)
    Net financial results   (1,830,367) (1,022,167)   (973,985) (616,223)
                 
    Share of results of associates and joint ventures   (2,738) (35,022)   (5,457) (31,452)
    Income before income tax   8,276,021  7,907,109    3,419,676  3,431,762 
                 
    Income tax expenses 9.2 (1,680,806) (1,651,039)   (629,110) (979,874)
    Net income   6,595,215  6,256,070    2,790,566  2,451,888 
                 
    Attributable to:            
    Equity holders of Ambev   6,411,668  6,096,585    2,717,722  2,396,309 
    Non-controlling interest   183,547  159,485    72,844  55,579 
                 
    Basic earnings per share – common – R$   0.4100  0.3873    0.1742  0.1523 
    Diluted earnings per share – common – R$   0.4081  0.3852    0.1734  0.1516 

     

    The accompanying notes are an integral part of these interim consolidated financial statements.

     

    AMBEV S.A.

     

    INTERIM CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME

    For the Six and three-month periods ended June 30

    All amounts in thousands of Brazilian Reais

     

      six-month period ended:   Three-month period ended:
      2025 2024   2025 2024
               
    Net income 6,595,215  6,256,070    2,790,566  2,451,888 
               
    Items that may be subsequently reclassified to profit or loss:          
    Exchange differences on the translation of foreign operations (gains/(losses))          
    Investment hedges – put options granted on subsidiaries 74,422  (96,686)   (1,433) (59,015)
    Gains/losses on translation of other foreign operations  (7,231,111) 5,307,415    (2,287,174) 4,316,352 
    Gains/losses on translation of foreign operations  (7,156,689) 5,210,729    (2,288,607) 4,257,337 
               
    Cash flow hedge – gains/(losses)          
    Recognized in equity (Hedge reserve) (822,134) 286,203    (385,466) 803,318 
    Reclassified from equity (hedge reserve) to profit or loss (522,155) (38,360)   (71,331) (123,309)
    Total cash flow hedge (1,344,289) 247,843    (456,797) 680,009 
               
    Items that will not be reclassified to profit or loss:          
    Re-measurements of post-employment benefits (1,036) 861    (1,124) (554)
               
    Other comprehensive (loss)/income (8,502,014) 5,459,433    (2,746,528) 4,936,792 
               
    Total comprehensive (loss)/income (1,906,799) 11,715,503    44,038  7,388,680 
               
    Attributable to:          
    Equity holders of Ambev (1,965,687) 11,454,382    12,312  7,251,727 
    Non-controlling interest 58,888  261,121    31,726  136,953 

     

    The consolidated statement of comprehensive income is presented net of income tax. The income tax effects of these items are disclosed in note 9.1 –Income tax and social contribution.

     

     

     

    The accompanying notes are an integral part of these interim consolidated financial statements.

     

    AMBEV S.A.

     

    INTERIM CONSOLIDATED STATEMENT OF CHANGES IN EQUITY

    For the six-month periods ended June 30

    All amounts in thousands of Brazilian Reais

     

        Attributable to the equity holders of Ambev      
        Issued capital Capital reserves Profit reserves Retained earnings Carrying value adjustments Total   Non-controlling interest Total equity
    At January 1, 2024 Note 58,177,929  55,479,564  43,189,840  -    (77,878,043) 78,969,290    1,174,512  80,143,802 
                         
     Net Income    -    -    -    6,096,585  -    6,096,585    159,485  6,256,070 
                               
    Comprehensive income:                          
    Gains/(losses) on cumulative translation adjustment [CTA] 15.4 -    -    -    -    5,112,045  5,112,045    98,684  5,210,729 
    Cash flow hedges 15.4 -    -    -    -    244,864  244,864    2,979  247,843 
    Actuarial gains/(losses) 15.4 -    -    -    -    888  888    (27) 861 
    Total comprehensive income    -    -    -    6,096,585  5,357,797  11,454,382    261,121  11,715,503 
    Capital increase 15.1 48,107  -    -    -    -    48,107    -    48,107 
    Effects of the application of IAS 29 (hyperinflation)   -    -    -    4,463,983  -    4,463,983    9,227  4,473,210 
    Gains/(losses) of controlling interest 15.2 e 15.4 -    1,958  -    -    512,385  514,343    (518,738) (4,395)
    Taxes on deemed dividends   -    -    -    -    (7,089) (7,089)   -    (7,089)
    Dividends   -    -    -    -    -    -      (154,147) (154,147)
    Share buybacks, results from treasury shares, and share-based payments 15.2 -    (201,060) -    -    -    (201,060)   601  (200,459)
    Statute-barred /(additional) dividends   -    -    -    20,820  -    20,820    -    20,820 
    At June 30, 2024   58,226,036  55,280,462  43,189,840  10,581,388  (72,014,950) 95,262,776    772,576  96,035,352 

     

     

     

    The accompanying notes are an integral part of these interim consolidated financial statements.

     

    AMBEV S.A.

     

    INTERIM CONSOLIDATED STATEMENT OF CHANGES IN EQUITY (CONTINUED)

    For the six-month periods ended June 30

    All amounts in thousands of Brazilian Reais

     

        Attributable to the equity holders of Ambev      
        Issued capital Capital reserves Profit reserves Retained earnings Carrying value adjustments Total   Non-controlling interest Total equity
    At January 1, 2025 Note 58,226,036  55,336,410  53,637,019  -    (68,557,326) 98,642,139    938,375  99,580,514 
                         
     Net Income    -    -    -    6,411,668  -    6,411,668    183,547  6,595,215 
                         
    Comprehensive income:                    
    Gains/(losses) on cumulative translation adjustment [CTA] 15.4 -    -    -    -    (7,030,017) (7,030,017)   (126,672) (7,156,689)
    Cash flow hedges 15.4 -    -    -    -    (1,346,338) (1,346,338)   2,049  (1,344,289)
    Actuarial gains/(losses) 15.4 -    -    -    -    (1,000) (1,000)   (36) (1,036)
    Total comprehensive income    -    -    -    6,411,668  (8,377,355) (1,965,687)   58,888  (1,906,799)
    Capital increases/(reduction) in associates and subsidiaries 15.1 49,660  -    -    -    -    49,660    (28,033) 21,627 
    Effects of the application of IAS 29 (hyperinflation)   -    -    -    1,376,923  -    1,376,923    (4,298) 1,372,625 
    Gains/(losses) of controlling interest 15.4 -    -    -    -    1,825  1,825    (1,848) (23)
    Taxes on deemed dividends 15.4 -    -    -    -    (4,196) (4,196)   -    (4,196)
    Dividends 15.3.2 -    -    (496,600) (3,501,638) -    (3,998,238)   (224,559) (4,222,797)
    Share buybacks, results from treasury shares, and share-based payments 15.2 -    (1,668,656) -    -    -    (1,668,656)   796  (1,667,860)
    Statute-barred /(additional) dividends   -    -    -    37,866  -    37,866    -    37,866 
    At June 30, 2025   58,275,696  53,667,754  53,140,419  4,324,819  (76,937,052) 92,471,636    739,321  93,210,957 

     

     

     

    The accompanying notes are an integral part of these interim consolidated financial statements.

     

     

    AMBEV S.A.

     

    INTERIM CONSOLIDATED STATEMENT OF CASH FLOWS

    For the Six and three-month periods ended June 30

    All amounts in thousands of Brazilian Reais

        six-month period ended:   Three-month period ended:
      Note 2025 2024   2025 2024
                 
    Net income   6,595,215  6,256,070    2,790,566  2,451,888 
    Adjustments:            
    Depreciation, amortization and impairment   3,415,654  3,352,178    1,702,403  1,719,851 
    Impairment losses on receivables and inventory   139,084  177,303    59,730  82,323 
    Additions to/(reversals of) provisions and employee benefits   199,577  131,043    80,482  75,270 
    Net financial results 20 1,830,367  1,022,167    973,985  616,223 
    Losses/(gains) on sales of property, plant and equipment and intangible assets 18 (62,078) (41,889)   (29,488) (21,206)
    Share-based payment expenses   206,107  184,482    107,141  83,192 
    Income tax expenses 9.2 1,680,806  1,651,039    629,110  979,874 
    Share of results of associates and joint ventures   2,738  35,022    5,457  31,452 
    Hedge operations 22 (697,456) (29,469)   (111,485) (136,461)
    Cash flow from operating activities before changes in working capital   13,310,014  12,737,946    6,207,901  5,882,406 
                 
    (Increase)/decrease in trade and other receivables   921,343  (283,988)   208,739  (370,764)
    (Increase)/decrease in inventories   (555,186) (1,349,392)   457,223  (357,858)
    Increase/(decrease) in trade and other payables   (6,976,274) (4,373,318)   (2,931,174) (1,308,550)
    Cash generated from operations   6,699,897  6,731,248    3,942,689  3,845,234 
                 
    Interest paid   (379,302) (270,724)   (141,796) (126,933)
    Interest received   649,457  752,671    282,825  361,854 
    Dividends received   7,012  11,379    2,459  4,715 
    Income tax paid   (2,723,052) (3,148,249)   (1,036,137) (726,744)
    Cash flow from operating activities   4,254,012  4,076,325    3,050,040  3,358,126 
                 
    Proceeds from sales of property, plant and equipment and intangible assets   66,714  90,963    34,604  54,746 
    Acquisitions of property, plant and equipment and intangible assets   (1,916,354) (2,043,986)   (1,088,203) (1,028,091)
    Sale/(acquisition) of subsidiaries, net of cash acquired   (40,213) 3,559    57  3,837 
    Investments in short-term debt securities and net proceeds/(acquisitions) of debt securities   142,411  (909,224)   91,166  (109,548)
    Net proceeds/(acquisitions) of other assets   1,734  -      1,115  -   
    Cash flow from/(used in) investing activities   (1,745,708) (2,858,688)   (961,261) (1,079,056)
                 
    Capital increases(reduction)/ in associates and subsidiaries   21,627  17,486    (2,066) -   
    Capital increases/(reduction) in non-controlling interest   -    (1,297)   -    (1,297)
    Proceeds from/(buybacks of) treasury shares   (1,831,123) (367,327)   (774,602) (291,104)
    Acquisitions of non-controlling interest   (23) (1,716,959)   -    (2,930)
    Proceeds from borrowing   50,682  433,243    42,919  20,352 
    Repayments of borrowing   (91,413) (507,841)   (42,243) (444,535)
    Cash net of finance costs other than interest   (1,650,121) (1,093,764)   (810,909) (547,677)
    Payments of lease liabilities   (594,254) (667,318)   (292,287) (346,083)
    Dividends and interest on capital paid   (8,691,998) (97,556)   (2,080,560) (85,957)
    Cash flow from/(used in) financing activities   (12,786,623) (4,001,333)   (3,959,748) (1,699,231)
                 
    Net increase/(decrease) in cash and cash equivalents   (10,278,319) (2,783,696)   (1,870,969) 579,839 
    Cash and cash equivalents at the beginning of the period   28,595,666  16,059,003    19,118,354  12,844,524 
    Effects of exchange rate fluctuations on cash and cash equivalents   (1,913,322) 879,127    (843,360) 730,071 
    Cash and cash equivalents at the end of the period   16,404,025  14,154,434    16,404,025  14,154,434 

     

    The accompanying notes are an integral part of these interim consolidated financial statements.

     

     

     

    AMBEV S.A.

     

     

    1.CORPORATE INFORMATION

     

    1.1 Description of business

     

    Ambev S.A. (referred to as the “Company” or “Ambev”) together with its subsidiaries (the “Group” or “Consolidated”), headquartered in São Paulo, São Paulo State, Brazil, has as its corporate purpose the production and sale of beer, draft beer, soft drinks, other non-alcoholic beverages, malt and food in general, either directly or through participation in other companies, as well as the advertising of both its own and of third party products, the sale of promotional and advertising materials, and the direct or indirect exploitation of bars, restaurants, snack bars and similar establishments, among others.

     

    The Group’s main own brands are Brahma®, Skol®, Antarctica®, Original®, Quilmes®, Andes Origen®, Patricia®, Paceña®, Huari®, Pilsen®, Presidente®, Balboa®, Guaraná Antarctica® and Beats® among others. The main licensed brands by Anheuser-Busch InBev N.V. (“AB InBev”) to the Group are Budweiser®, Corona®, Spaten®, Stella Artois®, Beck’s®, Modelo®, Bud Light®, Busch® and Michelob Ultra® among others. In addition, the Company is one of the largest independent bottlers of PepsiCo in the world. The Group produces, sells and distributes in Brazil and in other countries in Latin America, products such as Pepsi®, H2OH! ®, Lipton IceTea® and the sports drink Gatorade® under a license from PepsiCo. The Group also has a licensing agreement with Red Bull® and other companies to distribute of its portifolio some sales channels and specific regions in Brazil and other markets.

     

    The Company’s shares and American Depositary Receipts (“ADRs”) are listed on the Brasil, Bolsa, Balcão S.A. (“B3”) exchange under the ticker “ABEV3” as well as on the New York Stock Exchange (“NYSE”) under the ticker “ABEV”, respectively. The Company’s direct controlling shareholders are Interbrew International GmbH (“ITW International”), and AmBrew S.à.r.l (“Ambrew”), both of which are subsidiaries of AB InBev.

     

    1.2 Key operating countries

     

    The Company operates its business across four reportable segments based on the geographical zones shown below:

     

     

     

     

    AMBEV S.A.

     

    1.3 Major corporate events in the three-month period ended June 30, 2025

     

    1.3.1 Distribution of dividends

     

    In a meeting held on May 07, 2025, the Board of Directors approved the distribution of dividends in the amount of R$ 0.1280 per share of the Company, based on the balances available in the extraordinary balance sheet dated as of March 31, 2025, of which the amount corresponding to the profit recorded in the period from January 1st to March 31, 2025 will be allocated to the minimum mandatory dividends for the 2025 fiscal year and the remainder will be allocated to the special profit reserve constituted in previous fiscal years, without income tax withholding, pursuant to applicable law. The aforementioned payment was made on July 07, 2025.

     

    1.3.2 Share buybacks program

     

    On October 30, 2024, the Board of Directors approved a share buybacks program for the repurchase of shares issued by the Company up to a limit of 155,159,038 common shares with the primary purpose of cancelation, and the shares not canceled may be held in treasury, transferred and/or used to cover any share delivery requirements contemplated in the Company’s share-based compensation plans. The buyback program has been completed on June 25, 2025, with the acquisition of all shares covered by the program, at a total cost of R$1,930,815,421. The transactions was executed through the brokerage firm Santander Corretora de Câmbio e Valores Mobiliários S.A. and UBS Brasil CCTVM S.A..

     

    1.3.3 Assets held for sale - SLU

     

    On December 26, 2024, the Company's subsidiary, Cervecería Nacional Dominicana, S.A. ("CND"), and Koscab Holdings Limited ("Koscab") entered into an agreement ("Share Purchase Agreement") through which CND committed to transfer all the shares it holds in the holding company SLU Beverages LTD. ("SLU") to Koscab. The completion of the first two tranches of the operation became highly probable in June 2025. As a result, the assets and liabilities associated with SLU's operations were reclassified as assets held for sale and liabilities associated with assets held for sale in the consolidated interim financial statements for the period ended June 30, 2025, as disclosed in Note 8 - Assets and held for sale.

     

    2.BASIS OF PREPARATION AND PRESENTATION OF THE INTERIM CONSOLIDATED FINANCIAL STATEMENTS

     

    The interim consolidated financial statements at June 30, 2025 have been prepared using the going concern basis of accounting and are being presented in accordance with IAS 34 – Interim Financial Reporting as issued by the International Accounting Standards Board (“IASB®”).

     

    The information does not meet all disclosure requirements for the presentation of full annual consolidated financial statements and are disclosed with relevant information and changes in the period, without the level of detail in certain accompanying notes previously disclosed, avoiding repetition which, in Management's view, provides sufficient understanding of the Company's equity position and performance during the interim period. Therefore, the consolidated interim financial statements should be read in conjunction with the consolidated financial statements for the year ended December 31, 2024, prepared in accordance with International Financial Reporting Standards (“IFRS®”) issued by the IASB®.

     

     

    AMBEV S.A.

     

     

    The following notes are not disclosed in the interim consolidated financial statements:

     

      Name of accompanying note in annual financial statements Accompanying note
    (a) Payroll and related benefits 9
    (b) Additional information on cost of sales and operating expenses by nature 10
    (c) Earnings per share 12
    (d) Impairment of non-financial assets 16
    (e) Intangibles 17
    (f) Trade receivables 20
    (g) Employee benefits 24

     

    In addition, the material accounting policies presented in the respective accompanying notes are not disclosed in these interim consolidated financial statements. The following notes are not in the same level of detail presented in the annual consolidated financial statements, for the year ended December 31, 2024:

     

      Name of accompanying note in annual financial statements Accompanying note
    (a) Basis of preparation and presentation of the interim consolidated financial statements 2
    (b) Summary of material accounting policies 3
    (c) Use of estimates and judgments 4
    (d) Income tax and social contribution 13
    (e) Goodwill 15
    (f) Changes in equity 22
    (g) Interest-bearing loans and borrowing 23
    (h) Share-based payments 25
    (i) Provisions, contingent liabilities and contingent asset 27
    (j) Financial instruments and risks 28
    (k) Related parties 30

     

    In preparing the interim consolidated financial statements, management uses judgments, estimates and assumptions that affect the application of accounting practices and the reported amounts of assets, liabilities, income and expenses. The relevant estimates and judgments are disclosed in note 4 - Use of estimates and judgments.

     

    The interim consolidated financial statements relating to the period ended June 30, 2025 were approved by the Executive Board of Officers on July 30, 2025.

     

    2.1 Functional and presentation currency

     

    The functional and presentation currency of the Company interim consolidated financial statements is the Brazilian Real, which is the currency of its main economic operating environment. For presentation purposes, the interim consolidated financial statements are presented in thousands of Brazilian Reais (“R$”), unless otherwise indicated, and the balances are rounded to the nearest thousand.

     

     

    AMBEV S.A.

     

     

    2.1.1 Exchange rates

     

    The most significant exchange rates used for the preparation of the Company’s interim consolidated financial statements are as follow:

     

          Closing rate   Average rate
              six-month period ended:
    Currency Name Country 06/30/2025 12/31/2024   06/30/2025 06/30/2024
                   
    ARS Argentinian Peso  Argentina 0.0046  0.0060    0.0052  0.0058 
    BBD Barbadian Dollar Barbados 2.6901  3.0525    2.8744  2.4767 
    BOB Bolivian Peso Bolivia 0.7841  0.8897    0.8378  0.7218 
    CAD Canadian Dollar Canada 3.9906  4.3037    4.1210  3.7058 
    CLP Chilean Peso Chile 0.0058  0.0062    0.0060  0.0054 
    GTQ Quetzal Guatemala 0.7059  0.8051    0.7580  0.6455 
    USD US Dollar Panamá and Cuba 5.4571  6.1923    5.8310  5.0241 
    PYG Guarani Paraguay 0.0007  0.0008    0.0007  0.0007 
    DOP Dominican Peso Dominican Republic 0.0908  0.1010    0.0954  0.0853 
    UYU Uruguayan Peso Uruguay 0.1380  0.1405    0.1366  0.1297 

     

    3.SUMMARY OF MATERIAL ACCOUNTING POLICIES

     

    The accounting practices adopted by the Company are consistent for all the years and periods presented. There were no changes to the accounting policies or calculation methods used for the interim consolidated financial statements at June 30, 2025 compared to those used for the consolidated financial statements for the years ended December 31, 2024.

     

    3.1 Recently issued IFRS

     

    The following new and amended standards that came into effect in 2025 were not applicable to or did not have any material impact on these consolidated financial statements:

     

    Standard Highlights
    IAS21 - The Effects of Changes in Foreign Exchange Rates The implemented modifications foresee the application of a consistent approach when assessing whether one currency can be converted into another, along with new guidance regarding measurement and disclosure in contexts where the currency is not considered convertible.

     

    The following are the main changes in accounting standards that, based on Management's assessment, may have an impact on the Company's disclosures in subsequent periods:

     

    Standard Issue Date Highlights Effective  date
    IFRS 18 - Presentation and Disclosure in Financial Statements April 2024 The standard aims to address investor demands for more relevant and comparable information disclosed in the financial statements of entities. IFRS 18 introduces changes to the income statement with three new categories of revenues and expenses - operating, investing, and financing - two mandatory subtotals, and changes in the grouping of balances. Additionally, it requires disclosures in the notes regarding performance measures defined by management, changes in the statement of cash flows, and new presentation requirements for expenses by nature or function. The Company is currently in the process of evaluating the impacts of adopting this standard on consolidated financial statements. Periods beginning on January 1, 2027

     

    Beyond the above, the Company does not anticipate that any other standards or amendments to IFRS® standards or IFRIC® interpretations that have not yet come into force could have a material impact on the Group's financial statements. The Company has not opted for the early adoption of any standards.

     

     

    AMBEV S.A.

     

     

    4.USE OF ESTIMATES AND JUDGMENTS

     

    The preparation of interim consolidated financial statements in compliance with IFRS requires Management to make use of judgments, estimates and assumptions that affect both the application of accounting practices and the reported amounts of assets and liabilities, income and expenses. The estimates and significant judgment are based on past experience and on other factors that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments regarding the carrying amounts of assets and liabilities that cannot readily be determined based on other sources. The actual results achieved may differ from these estimates.

     

    Such estimates and assumptions are reviewed on a regular basis. Changes in accounting estimates may affect the results for the period during which they are realized, or for future periods.

     

    The accounting policy which reflects significant estimates and judgments used in the preparation of these interim consolidated financial statements for the six-month period ended June 30, 2025 has not changed from those valid on December 31, 2024.

     

    5.CASH AND CASH EQUIVALENTS AND INVESTMENT SECURITIES

     

    5.1 Cash and equivalents

     

      06/30/2025 12/31/2024
         
    Cash 82,580  222,651 
    Current bank accounts 8,562,916  11,395,378 
    Short-term bank deposits (i) 7,758,529  16,977,637 
    Net cash and cash equivalents 16,404,025  28,595,666 

     

    (i) The balance refers mostly to Bank Deposit Certificates (“CDBs”), which have high liquidity, are readily convertible into known amounts of cash, and are subject to an insignificant risk of changes in value.

     

    The cash and cash equivalents balance include the amount of R$5,469,634 at June 30, 2025 (R$8,038,817 in December 31, 2024), which is not freely remittable to the parent company due to remittance restrictions in Cuba and Argentina, and due to the unavailability of foreign currency in Bolivia, although it is available for use in the local operations of those subsidiaries.

     

    5.2 Investment securities

     

      06/30/2025 12/31/2024
         
    Financial assets at fair value through profit or loss 1,106,252  1,170,496 
    Investments in debt securities 14,301  71,505 
    Current assets 1,120,553  1,242,001 
         
    Investments in debt securities (i) 103,503  184,454 
    Non-current assets 103,503  184,454 
         
    Total 1,224,056  1,426,455 

     

    (i) The balance refers substantially to financial investments linked to tax incentives that are not immediately convertible into a known amount of cash.

     

     

    AMBEV S.A.

     

     

    6.INVENTORIES

     

      06/30/2025 12/31/2024
         
    Finished goods  4,423,255  3,903,163 
    Work in progress 642,050  738,987 
    Raw materials and consumables 5,060,986  5,622,197 
    Spare parts and others 921,948  996,505 
    Inventory in transit and prepayments 397,552  569,961 
    Impairment losses (94,161) (141,046)
      11,351,630  11,689,767 

     

    The changes in impairment losses on inventory are as follow:

     

      06/30/2025 12/31/2024
    Balance at the end of the previous year (141,046) (142,447)
    Effects of cumulative translation adjustments (CTA) 7,638  (16,699)
    Provisions (98,712) (263,999)
    Write-offs/reversal of provisions 134,141  282,099 
    Reclassified to assets held for sale (i) 3,818  -   
    Balance at the end of the period (94,161) (141,046)

     

    (i) Effect related to the reclassification of SLU's asset balances to the line of assets held for sale, as note 8 - Assets and liabilities held for sale.

     

    7.RECOVERABLE TAXES

      06/30/2025 12/31/2024
    Exclusion of ICMS from PIS/COFINS (i) 271,099  307,746 
    PIS/COFINS 170,906  134,570 
    ICMS 510,442  359,875 
    IPI 134,148  119,599 
    Income tax and social contributions 2,604,058  2,582,088 
    Other 45,876  78,397 
    Current 3,736,529  3,582,275 
         
    Exclusion of ICMS from PIS/COFINS (i) 6,998,751  6,790,088 
    PIS/COFINS 126,102  148,140 
    ICMS 348,418  378,226 
    Income tax and social contributions 2,335,108  2,922,517 
    Other 257,069  265,006 
    Non-current 10,065,448  10,503,977 
         
    Total 13,801,977  14,086,252 

     

    (i) Over the past few years, as previously disclosed, the Company has recognized PIS/COFINS credits arising from the exclusion of ICMS, including in the form of tax substitution, from the calculation bases of these contributions. These tax credits were recorded against the recoverable taxes in the balance sheet, in the PIS/COFINS – ICMS exclusion line, as shown in the table above. The amounts that have not yet been offset substantially refer to tax credits from Regime Especial de Tributação de Bebidas Frias (“REFRI”), for the period from 2009 to 2015, in relation to which the lawsuit is currently in the expert evaluation phase.

     

     

    AMBEV S.A.

     

     

    8.ASSETS AND LIABILITIES HELD FOR SALE

    As disclosed in Note 1 - Coporate Information, the Company's subsidiary, CND, and Koscab entered into a Share Purchase Agreement through which CND committed to transfer all shares it holds in SLU to Koscab, in exchange for the minimum estimated amount of US$186 million, equivalent to R$1,017 million, deferred in up to five tranches until 2028.

     

    The SLU is the majority shareholder of Banks Holdings Limited, Saint Vincent Brewery Limited, Antigua Brewery Limited e Dominica Brewery & Beverages Limited, which are part of the reportable segment CAC.

     

    In June 2025, after the completion of the main precedent conditions, the closing of the first two tranches became highly probable and was agreed to occur by July 31, 2025, date in which CND will transfer to Koscab 61.83% of the interest held by in SLU. In compliance with IFRS5 - Non-current Assets Held for Sale and Discontinued Operations, the assets and liabilities associated with SLU's operations were reclassified as held for sale in the period.

     

    8.1 assets and liabilities held for sale

     

    The relevant assets and liabilities are detailed in the tables below:

     

    Assets 06/30/2025
    Trade receivables and inventories 160,124 
    Property, plant and equipment and intangible assets 271,535 
    Goodwill 124,199 
    Other assets 135,833 
    Assets held for sale 691,691 
       
    Liabilities 06/30/2025
    Trade payables and other liabilities 102,082 
    Dividends and interest on capital payables 33,174 
    Liabilities associated with assets held for sale 135,256 

     

     

    AMBEV S.A.

     

     

    9.INCOME TAX AND SOCIAL CONTRIBUTION

     

    9.1 Deferred income tax and social contribution

     

    The amounts of deferred income tax and social contribution for each type of temporary difference are as shown below:

     

      06/30/2025   12/31/2024
      Assets Liabilities Net   Assets Liabilities Net
    Investment securities 7,024  -    7,024    7,299  -    7,299 
    Intangibles -    (1,912,959) (1,912,959)   -    (2,141,921) (2,141,921)
    Employee benefits 849,329  -    849,329    971,593  -    971,593 
    Trade payables 3,414,862  (2,174) 3,412,688    3,880,182  -    3,880,182 
    Trade receivables 36,482  (6,200) 30,282    35,098  (6,676) 28,422 
    Derivative financial instruments 51,975  (24,594) 27,381    37,725  (246,083) (208,358)
    Interest-bearing loans and borrowings 10,174  -    10,174    8,817  -    8,817 
    Inventories 409,603  (96,350) 313,253    307,006  (205,882) 101,124 
    Property, plant and equipment 1,032,419  (2,116,376) (1,083,957)   1,189,580  (2,459,042) (1,269,462)
    Withholding tax on undistributed profits and royalties -    (2,441,013) (2,441,013)   -    (2,254,977) (2,254,977)
    Investments in associates and joint ventures -    (383,678) (383,678)   -    (383,678) (383,678)
    Interest on capital 594,714  -    594,714    -    -    -   
    Tax losses carried forward (i) 4,118,990  -    4,118,990    3,849,724  -    3,849,724 
    Provisions 1,395,733  (2,445) 1,393,288    1,537,883  (4,542) 1,533,341 
    Complement of income tax of foreign subsidiaries due in Brazil -    (80,582) (80,582)   -    -    -   
    Impact of IFRS 16 (Leases) 3,085  (68,615) (65,530)   -    (47,089) (47,089)
    Exclusion of ICMS from PIS/COFINS calculation basis -    (82,550) (82,550)   -    (121,590) (121,590)
    Other items 216,537  (260,731) (44,194)   289,258  (558,726) (269,468)
    Gross deferred tax assets/(liabilities) 12,140,927  (7,478,267) 4,662,660    12,114,165  (8,430,206) 3,683,959 
    Netting by taxable entity (3,258,762) 3,258,762  -      (3,422,495) 3,422,495  -   
    Net deferred tax assets/(liabilities) 8,882,165  (4,219,505) 4,662,660    8,691,670  (5,007,711) 3,683,959 

     

    (i) Historically, tax authorities have offset tax losses ex officio in administrative proceedings in which the Company and some of its subsidiaries are involved, resulting in an accumulated offset of R$268,602. This amount is included in the tax credits recognized under the line of tax losses carried forward. As of June 30, 2025, the amount remained unchanged since there were no new ex officio offsets during the period. The processes in question have a probability of a possible loss.

     

    9.1.1 Realization of deferred taxes

     

    At June 30, 2025, the deferred tax assets and liabilities expected to be utilized/settled, not related to tax losses, are: (i) to be realized until 12 months R$1,497,425; and (ii) to be realized after 12 months R$(953,755).

     

    9.1.2 Net change in deferred taxes

     

    The net change in deferred income tax and social contribution is as follows:

     

    At December 31, 2024 3,683,959 
    Recognition of actuarial gains/(losses) 94 
    Investment hedges – put options granted on subsidiaries (38,338)
    Cash flow hedge – gains/(losses) 435,332 
    Gains/(losses) on cumulative translation adjustments [CTA]  555 
    Recognized in other comprehensive income 397,643 
    Recognized in the income statement 627,245 
    Changes recognized directly in the balance sheet (46,187)
    Recognized in deferred tax (192,593)
    Effects of the application of IAS 29 (hyperinflation) (192,593)
    Recognized in the other balance sheet group 146,406 
    At June 30, 2025 4,662,660 

     

     

    AMBEV S.A.

     

    9.1.3 Deferred tax assets related to tax losses

     

    Beyond the tax credits related to tax losses effectively recognized as part of the amounts disclosed above, there are other tax credits related to tax losses that were not recorded in the balance sheets due to their low expectations of realization, based on Management’s assessment. At June 30, 2025, the accumulated balance of these credits represented R$856,562 in taxable value (R$866,979 in December 31, 2024) equivalent to a taxable basis of R$3,261,137 in June 30, 2025 (R$3,310,110 in December 31, 2024).

     

    9.2 Income tax and social contribution

     

    The income taxes reported in the income statement are broken down as follows:

     

      six-month period ended:   Three-month period ended:
      06/30/2025 06/30/2024   06/30/2025 06/30/2024
    Income tax expenses – current (2,308,051) (2,112,866)   (1,151,428) (1,109,704)
               
    Deferred tax expenses on temporary differences 357,979  926,473    219,863  554,551 
    Deferred tax on taxes loss carryforward movements in the current period 269,266  (464,646)   302,455  (424,721)
    Total deferred tax (expenses)/income 627,245  461,827    522,318  129,830 
               
    Total income tax expenses (1,680,806) (1,651,039)   (629,110) (979,874)

     

    The reconciliation between the weighted nominal tax rate and the effective tax rate is summarized below:

     

      six-month period ended:   Three-month period ended:
      06/30/2025 06/30/2024   06/30/2025 06/30/2024
    Profit before income tax 8,276,021  7,907,109    3,419,676  3,431,762 
    Adjustments to the taxable basis          
    Other non-taxable income (330,312) (253,909)   (167,700) (123,286)
    Government grants related to taxes on sales (193,898) -      (96,892) -   
    Share of results of associates and joint ventures 2,738  35,022    5,457  31,452 
    Non-deductible expenses 305,269  34,800    64,652  27,885 
    Taxation on a universal basis and other adjustments related to foreign subsidiaries 4,993  (66,097)   70,225  (54,094)
      8,064,811  7,656,925    3,295,418  3,313,719 
    Aggregated weighted nominal tax rate 27.58% 29.37%   27.50% 28.38%
    Taxes payable – nominal rate  (2,224,133) (2,249,129)   (906,137) (940,439)
    Adjustments to tax expenses          
    Income tax incentives 108,140  324,271    64,506  75,732 
    Deductible interest on capital 594,714  511,038    272,071  225,925 
    Tax savings arising from the amortization of goodwill 1,793  1,793    897  897 
    Withholding income tax (103,527) (409,912)   (59,831) (304,732)
    Recognition/(write-off) of deferred charges on tax losses (45,454) (31,425)   (17,648) (109,720)
    Effects of the application of IAS 29 (hyperinflation) (27,941) 57,516    (19,717) 5,224 
    Others with reduced taxation 15,602  144,810    36,749  67,240 
    Income tax and social contribution expense (1,680,806) (1,651,038)   (629,110) (979,873)
    Effective tax rate 20.31% 20.88%   18.40% 28.55%

     

    The main events that impacted the effective tax rate for the period were:

     

    ·Other non-taxable income: it refers mainly to the revenues arising from monetary updates (Selic) on tax credits.

     

    ·Government grants related to taxes on sales: these represent regional incentives and economic development policies, primarily related to local production to generate economic and social impact. Before the advent of Federal Law No. 14,789/2023, those grants were not subject to income tax and social contribution. In this regarding, since August 2024 companies in the grouphave obtained favorable decisions, in effect since then, exempting them from collecting IRPJ and CSLL on amounts determined as government grants related to tax benefits deemed as ICMS presumed credits.
     

    AMBEV S.A.

     
    ·Non-deductible expenses: primarily refer to the additional costs incurred in acquiring foreign currency in certain jurisdictions where the Group operates, used for payments to some suppliers, as well as for the remittance of earnings to the parent companies.

     

    ·Taxation on a universal basis and other adjustments related to foreign subsidiaries: the additional income taxes due in Brazil on the income of foreign-controlled entities, in accordance with Law No. 12,973/14. It also includes local permanent adjustments to foreign companies consolidated within the group, as well as the effects arising from some of these companies having a functional currency that differs from the currency used for tax calculations.

     

    ·Income tax incentives: it refers to tax incentives related to income tax granted by the Brazilian Federal Government to promote regional development in certain areas of the North and Northeast of the country and to the PAT (“Programa de Alimentação do Trabalhador”). These incentives are recorded in the results on an accruals basis and allocated to fiscal incentives reserve, as per item (15.3.1) "Tax incentives" within note 15 – Changes in equity.

     

    ·Withholding income tax: this balance is related to tax due on dividends to be distributed by subsidiaries located outside of Brazil under local tax legislation. The recorded amounts in 2025 are mainly related to withholding tax calculated on profits earned in 2025 and to exchange differences on deferred income tax related to the undistributed profits of subsidiaries.

     

    ·Deductible interest on capital (“IOC”): under Brazilian law, companies have an option to remunerate their shareholders through the payment of IOC, which is deductible for income tax purposes. The amount of IOC is impacted by the taxable result, net income reserves of the Company and by the long-term interest rate (“TJLP”). These remunerations are deductible for income tax purposes.

     

    ·Effects of the application of IAS 29 (hyperinflation): the Company’s subsidiary in Argentina operates in a hyperinflationary economy thus subject to the monetary correction of its non-financial assets and liabilities, its equity and its statement of income, which may impact the consolidated effective tax rate, implying variation between periods.

     

    10.PROPERTY, PLANT AND EQUIPMENT

     

      06/30/2025 12/31/2024
    Property, plant and equipment 24,732,378  27,134,539 
    Right of use assets 2,746,453  3,035,655 
      27,478,831  30,170,194 

     

     

    AMBEV S.A.

     

    10.1 Changes in the carrying amount of property, plant, and equipment

     

                        Carrying amount
      At December 31, 2023 Cumulative translation adjustments (CTA) Effects of the application of IAS 29 (hyperinflation) Acquisitions  Depreciation Disposals and write-offs Transfers  At December 31, 2024   Acquisition cost Depreciation
    Land and buildings 9,236,261  635,379  1,165,836  38,174  (496,322) (35,129) 585,647  11,129,846    17,204,820  (6,074,974)
    Plant and equipment 10,788,846  743,990  1,238,477  720,451  (3,903,666) (4,132) 2,971,323  12,555,289    49,135,917  (36,580,628)
    Fixtures and accessories 1,091,672  62,277  95,292  75,467  (567,143) (21,854) 192,129  927,840    7,882,785  (6,954,945)
    Under construction 2,545,949  145,861  173,090  3,415,248  -    -    (3,758,584) 2,521,564    2,521,564  -   
    Total 23,662,728  1,587,507  2,672,695  4,249,340  (4,967,131) (61,115) (9,485) 27,134,539    76,745,086  (49,610,547)

     

                          Carrying amount
      At December 31, 2024 Cumulative translation adjustments (CTA) Effects of the application of IAS 29 (hyperinflation) Acquisitions  Depreciation Disposals and write-offs Transfers  Reclassified to assets held for sale (i) At June 30, 2025   Acquisition cost Depreciation
    Land and buildings 11,129,846  (836,337) 238,464  2,392  (241,846) (449) 203,013  (117,781) 10,377,302    16,343,280  (5,965,978)
    Plant and equipment 12,555,289  (870,139) 228,290  160,288  (1,906,685) (3,300) 1,123,106  (133,063) 11,153,786    46,766,224  (35,612,438)
    Fixtures and accessories 927,840  (56,340) 12,147  4,584  (220,674) (1,351) 195,518  (5,645) 856,079    7,426,707  (6,570,628)
    Under construction 2,521,564  (134,758) 37,241  1,502,779  -    -    (1,572,891) (8,724) 2,345,211    2,345,211  -   
    Total 27,134,539  (1,897,574) 516,142  1,670,043  (2,369,205) (5,100) (51,254) (265,213) 24,732,378    72,881,422  (48,149,044)

     

    (i) Effect related to the reclassification of SLU's asset balances to the line of assets held for sale, as note 8 - Assets and liabilities held for sale.

     

    AMBEV S.A.

     

    10.2 Changes in the carrying amount of right-of-use assets

     

                        Carrying amount
      At December 31, 2023 Cumulative translation adjustments (CTA) Effects of the application of IAS 29 (hyperinflation) Additions Depreciation Write-offs Transfers  At December 31, 2024   Acquisition cost Depreciation
    Buildings 1,172,266  102,809  4,152  449,236  (442,227) (46,420) (4,527) 1,235,289    3,474,376  (2,239,087)
    Machinery, equipment and vehicles 1,709,257  42,094  920  796,867  (802,095) (19,431) (1,287) 1,726,325    4,124,273  (2,397,948)
    Others 85,905  4,853  26,369  39,941  (75,813) (7,214) -    74,041    288,406  (214,365)
    Total 2,967,428  149,756  31,441  1,286,044  (1,320,135) (73,065) (5,814) 3,035,655    7,887,055  (4,851,400)

     

                        Carrying amount
      At December 31, 2024 Cumulative translation adjustments (CTA) Effects of the application of IAS 29 (hyperinflation) Additions Depreciation Write-offs Reclassified to assets held for sale (i) At June 30, 2025   Acquisition cost Depreciation
    Buildings 1,235,289  (55,076) 1,196  218,914  (243,615) (2,403) (383) 1,153,922    3,475,257  (2,321,335)
    Machinery, equipment and vehicles 1,726,325  (21,002) (186) 189,666  (368,561) (15,854) -    1,510,388    4,227,042  (2,716,654)
    Others 74,041  (5,652) 2,156  42,842  (31,244) -    -    82,143    256,994  (174,851)
    Total 3,035,655  (81,730) 3,166  451,422  (643,420) (18,257) (383) 2,746,453    7,959,293  (5,212,840)

     

    (i) Effect related to the reclassification of SLU's asset balances to the line of assets held for sale, as note 8 - Assets and liabilities held for sale.

     

     

    AMBEV S.A.

     
    11.GOODWILL

     

      06/30/2025 12/31/2024
         
    Balance at the end of the previous year 44,342,668  38,003,640 
    Effects of cumulative translation adjustments (CTA) (3,090,020) 3,723,544 
    Effects of the application of IAS 29 (hyperinflation) 537,340  2,628,891 
    Acquisitions/(write-offs) 14,538  (13,407)
    Reclassified to assets held for sale (i) (124,199) -   
    Balance at the end of the year 41,680,327  44,342,668 

     

    (i) Effect related to the reclassification of SLU's asset balances to the line of assets held for sale, as note 8 - Assets and liabilities held for sale.

     

    Impairment testing

    The impairment test is performed annually considering the most accurate estimates calculated by Management. The Company’s Management has not identified any relevant indications of impairment in the six-month period ended June 30, 2025.

     

    12.TRADE PAYABLES

     

      06/30/2025 12/31/2024
         
    Trade payables 18,987,312  24,042,927 
    Related parties 896,000  1,180,595 
    Current 19,883,312  25,223,522 
         
    Trade payables 80,751  69,368 
    Related parties 239,572  258,338 
    Non-current 320,323  327,706 
         
    Total 20,203,635  25,551,228 

     

    The present value adjustment related to the obligations recorded in trade payables, at June 30, 2025 is R$218,885 million (R$210,694 million at December 31, 2024).

     

    The subsidiaries in Argentina, Chile, and Panama have discount transactions for duplicates with endorsement (trade payables securitization) with vendors in the amount of R$68,910 million at June 30, 2025 (R$76,230 million at December 31, 2024). In general, the above-mentioned discount transactions occur as a result of legal impositions existing in these jurisdictions. These transactions maintain their commercial characteristics since there are no changes to the previously established conditions (amount, terms, and counterpart), and it is the vendor’s choice to anticipate its receivables, and therefore these transactions do not result in any additional obligations for the Company.

     

     

    AMBEV S.A.

     
    13.INTEREST-BEARING LOANS AND BORROWING

     

      06/30/2025 12/31/2024
         
    Secured bank loans 21,559  18,481 
    Other secured loans 152,975  145,150 
    Lease liabilities 926,044  1,112,760 
    Current liabilities 1,100,578  1,276,391 
         
    Secured bank loans 80,870  96,940 
    Other secured loans 218,364  227,089 
    Lease liabilities 1,757,952  1,852,308 
    Non-current liabilities 2,057,186  2,176,337 
         
    Total 3,157,764  3,452,728 

     

    Additional information regarding the exposure of the Company to interest rates, foreign currency risk and debt repayment schedule is disclosed in note 22 - Financial instruments and risks.

     

    13.1 Contractual clauses (covenants)

     

    At June 30, 2025, at December 31, 2024, and up to the date of issuance of these consolidated financial statements, no events of default, breaches of covenants, or significant contractual changes occurred that would result in changes to the payment terms of loan and financing agreements.

    13.2 Leasing contracts regarding the term and discount rate (Brazil)

     

    The Company estimated the discount rates based on the risk-free interest rates observable in the Brazilian market over the terms of its contracts, adjusted to its reality (i.e. the credit 'spreads'). These spreads are based on surveys conducted with financial institutions. The table below highlights the weighted average of the rates applied, considering the terms of the existing contracts:

     

      Rate %
    Lease Term 06/30/2025
     2025 - 2029  11.49%
     2030 - 2035  11.48%

     

    14.PROVISIONS, CONTINGENT LIABILITIES AND CONTINGENT ASSETS

     

    The Company and its subsidiaries are involved in administrative and judicial proceedings and arbitrations arising from the normal course of business. The assessment of the likelihood of loss, carried out by the Company with the support of its legal advisors, considers the likelihood of the Company position being accepted at the end of the proceedings, considering the applicable legislation, the case law on the subject and the existing evidence. Due to their nature, these proceedings involve inherent uncertainties, including, but not limited to, decisions by courts and tribunals agreements between the parties involved and governmental actions and, as a result, Management cannot, at this stage, estimate the precise timing to conclude such proceedings.

     

    14.1 Provisions

     

    The lawsuits considered probable of loss are fully provisioned, under the terms of IAS 37 - Provisions, Contingent Liabilities and Contingent Assets, and have a tax, civil or labor nature. Cases are considered likelihood of loss when there is established or binding case law unfavorable to the position defended by the Company and its subsidiaries, or, in the case of factual or evidentiary disputes, when the Company and its subsidiaries do not have the necessary and sufficient evidence to prove the claimed right.

     

    AMBEV S.A.

     

    14.1.1 Main lawsuits with a probable likelihood of loss

     

    Taxes on sales: in Brazil, the Company and its subsidiaries are parties to various administrative and judicial proceedings related to ICMS, IPI, PIS and COFINS taxes, considered as probable likelihood of loss. Such proceedings include, among others, tax offsetting, appropriation of tax credits and alleged insufficient payment of the respective taxes.

     

    Labor: the Company and its subsidiaries are parties to labor lawsuits considered likely to result in loss, involving former employees, including those from outsourced service providers. The main issues involve overtime and related effects and respective charges.

     

    Civil: the Company and its subsidiaries are involved in civil proceedings considered as representing a probable likelihood of loss. The most relevant portion of these lawsuits was filed by former distributors, mainly in Brazil, mostly claiming damages resulting from the termination of their contracts with the Company.

     

    Other taxes: refer to provisions for lawsuits concerning taxes unrelated to sales or income taxation. The uncertain tax treatments related to income taxes with a prognosis of probable loss have their value reported directly in the income tax and social contribution payable line, as per IFRIC 23 - Uncertainty on the Treatment of Income Taxes.

     

    14.1.2 Provisions changes

     

      Tax on sales Labor Civil Other taxes Restructuring Total
                 
    Balance at December 31, 2023 282,172  149,937  340,177  202,447  3,270  978,003 
    CTA effect -    1,285  305  12,416  654  14,660 
    Constituted provisions 148,661  294,740  144,887  39,769  24,754  652,811 
    Consumed provisions (33,554) (205,810) (89,949) (19,695) (24,106) (373,114)
    Reversed provisions (71,373) (45,042) (23,399) (20,731) -    (160,545)
    Balance at December 31, 2024 325,906  195,110  372,021  214,206  4,572  1,111,815 
    CTA effect -    (1,397) (2,662) (7,174) (335) (11,568)
    Constituted provisions 112,084  108,228  47,138  27,460  14,135  309,045 
    Consumed provisions (23,290) (72,593) (105,514) (7,820) (14,045) (223,262)
    Reversed provisions (21,632) (28,481) (108,691) (12,167) -    (170,971)
    Balance at June 30, 2025 393,068  200,867  202,292  214,505  4,327  1,015,059 

     

    14.1.3 Expected settlement of provisions

     

      06/30/2025   12/31/2024
      Current Non-current Total   Current Non-current Total
    Tax on sales 252,506  140,562  393,068    158,717  167,189  325,906 
    Labor 62,051  138,816  200,867    55,700  139,410  195,110 
    Civil 166,740  35,552  202,292    188,357  183,664  372,021 
    Other taxes 50,789  163,716  214,505    33,565  180,641  214,206 
    Total provision for disputes and litigation 532,086  478,646  1,010,732    436,339  670,904  1,107,243 
    Restructuring 4,327  -    4,327    4,572  -    4,572 
    Total provisions 536,413  478,646  1,015,059    440,911  670,904  1,111,815 

     

    The expected settlement of provisions was based on Management’s best estimate, in line with their internal and external legal advisors’ assessments, at the consolidated balance sheet date.

     

    AMBEV S.A.

     

    14.2 Contingencies

     

    The Company and its subsidiaries maintain administrative and judicial disputes with fiscal authorities in Brazil related to certain tax positions adopted when calculating the income tax and social contribution, which, based on Management’s current evaluation, probably are going to be accepted in superior court decisions of last instance, considering the regular compliance with tax laws, case law, and evidence produced, in line with IFRIC 23 - Uncertainty over Income Tax Treatments. The Group is also part on tax proceedings related to other taxes, which involve possible loss risk, according to Management's assessment. To these uncertain tax treatments and possible contingencies there are no constituted provision, due to the prognosis assessment carried out. Such proceedings represent the following estimates.

     

      06/30/2025 12/31/2024
         
    Income tax and social contribution 69,758,784  65,174,567 
    Value-added and excise duties 28,160,430  28,139,743 
    PIS and COFINS 1,795,420  2,032,464 
    Others 2,636,262  2,552,048 
      102,350,896  97,898,822 

     

    Contingencies with a remote risk of loss are not disclosed, as the possibility of any settlement is remote, in accordance with IAS 37 - Provisions, Contingent Liabilities and Contingent Assets.

     

    The Company and its subsidiaries have guarantee-insurance bonds and letters of guarantee for some legal proceedings, presented as guarantees on civil, labor and tax lawsuits.

     

    14.2.1 Main contingencies with a possible risk of loss

     

    The changes in the amount of contingencies reported relate mainly to the increase resulting from monetary restatement. In addition, the main process classified with a possible loss probability, which relevant changed until June 30, 2025, are summarized in the table below, along with their respective estimated values involved in the cases.

     

     

    Uncertainty over the treatment of income taxes

    In accordance with IFRIC 23 (note 9.1 - Income tax and social contribution)

    Estimates

    (in million of Brazilian Reais)

    # Description of the main processes 06/30/2025 12/31/2024
    1

    Disallowance of tax paid abroad

    Since 2014, the Company has been receiving tax assessments, relating to calendar years from 2007 onwards, which disallow the use of foreign tax credits relating to income tax paid abroad by its controlled companies. The Company is challenging these assessments in the administrative and judicial courts. In November 2019, a final favorable decision was issued by the Administrative Council of Tax Appeals (“CARF”) canceling the assessment regarding one of the cases, covering the calendar year 2010. For cases involving calendar years 2015 and 2016, the Company received unfavorable decisions, in the administrative level, in three out of four cases. The Company filed a lawsuit to discuss the matter and awaits a decision by the first-instance judicial court. In July 2024, the Lower Administrative Court rendered a favorable decision to the Company in one case related to the 2012 calendar year (approximately R$1.4 billion). The Company awaits the notification of the decision in order to assess, together with its external advisors, any potential impacts on the likelihood of loss of this portion of the contingency. In January 2025, the Company received new assessments related to the 2019 calendar year and submitted administrative defenses, which are pending judgment. The other cases are still awaiting final decisions at both administrative and judicial courts.

    In connection with the disallowance of tax paid abroad, the RFB filed additional tax assessments to charge isolated fines due to the lack of monthly prepayments of income tax as a result of allegedly undue deductions of taxes paid abroad. The Company has received tax assessments charging such fines for the calendar years 2015 to 2019. For the tax assessments related to the periods of 2016, 2018 and 2019, Ambev received unfavorable decisions from the first-level administrative court and filed appeals in connection therewith, which are pending judgment by the Lower Administrative Court. In August 2024, for the tax assessments related to the periods of 2015 and 2017, Ambev received an unfavorable decision by the Lower Administrative Court for the case related to the calendar year of 2015, against which it filed an appeal to the Upper Administrative Court, and a favorable decision for the case related to the calendar year of 2017, which is not final and appealed by the tax authorities.

    The updated assessed value of this uncertain tax treatment, in accordance with IFRIC 23 - Uncertainty over Income Tax Treatments, is approximately R$18.2 billion as of June 30, 2025 (R$15.9 billion as of December 31, 2024), and, due to the assessment of the likelihood of loss, no provision was made in the period. This uncertain tax treatment, according to IFRIC, regarding income tax credits paid abroad, continued to be applied by the Company and impacted subsequent calendar years to those assessed (2018, 2020-2024). If new questions arise in the future, on the same basis and with the same grounds as the tax assessments mentioned, the Company estimates that the outcome of these potential new discussions would be consistent with the periods already assessed.

     

    18,232 15,932
     

    AMBEV S.A.

     
      Indirect taxes

    Estimates

    (in million of Brazilian Reais)

    # Description of the main process 06/30/2025 12/31/2024
    1

    ICMS-ST Trigger

    Over the years, Ambev has received tax assessments to charge supposed ICMS differences considered due when the price of the products sold by Ambev is above the fixed price table basis established by the relevant states, cases in which the state tax authorities contend that the calculation basis should be based on a value-added percentage over the actual prices and not the fixed table price. Ambev is currently challenging those charges before the courts. The cases are being challenged at both the administrative and judicial levels. In February 2025, the Supreme Court rendered its judgment on Topic 816, establishing a limit of 20% for late payment fines. This decision is applicable to certain cases under consideration and represents a reclassification of potential loss from possible to remote, amounting to 0.8 billion reais. A Company estimates that the total updated amount of possible risk involved in the processes related to this matter, as of June 30, 2025, is approximately R$11.3 billion (R$12 billion on December 31st, 2024).

    11,334 11,966

     

    14.2.2 Tax Proceeding Initiated by the Group 

     

    The Company is also a party on other tax proceedings in which it is the plaintiff and discusses the possibility of recovering or avoiding the payment of taxes that, in the Administration's view, lack constitutional and/or legal support for their enforcement. As disclosed on the accounting policy, the Company does not recognize contingent assets in its financial statements. If the inflow of economic benefits becomes probable, based on a forecast assessment conducted by external legal advisors in conjunction with the internal assessment of the Administration, the Company discloses the contingent asset. When the inflow of economic benefits becomes virtually certain, such as when a final judgment is rendered in the case and the gain can be reliably estimated, the asset is no longer contingent, and the Company recognizes it in the financial statements in period in which the estimate has changes.

     

    The contingent assets with relevant changed until June 30, 2025, are summarized in the table below.

     

      Contingent assets
    # Description of the main processes
    1

    Cerbuco Brewing Inc. arbitration

    Cerbuco Brewing Inc. (“Cerbuco”), a Canadian subsidiary of Ambev, owns a 50% equity ownership in Cerveceria Bucanero S.A. (“Bucanero”), a joint venture in Cuba. In 2021, Cerbuco initiated an arbitration proceeding at the International Chamber of Commerce (“ICC”), relating to a potential breach of certain obligations in connection with the joint venture. On 24 October 2024, the ICC released an arbitration award partially favorable to Cerbuco. The decision is final and the second phase of the arbitration for quantification of damages is ongoing. In May 2025, Cerbuco was notified of an annulment action filed by Coralsa (its partner in the joint venture) in Paris, against the arbitral award. The proceedings are ongoing, and no decision has been rendered in the case to date. The outcome of both proceedings which may trigger other actions, including reevaluating IFRS 10 - Consolidated Financial Statements application.

     

     

    AMBEV S.A.

     
    15.CHANGES IN EQUITY

     

    15.1 Issued capital

     

    At June 30, 2025, the authorized issued capital, fully subscribed and paid in amounting to R$58,275,696 (R$58,226,036 in June 30, 2024) was composed of 15,761,639 common shares (15,757,657 in June 30, 2024), book entry, nominative, without nominal value, distributed as follows:

     

      06/30/2025   06/30/2024
    Shareholder Thousands of common shares %   Thousands of common shares %
    Interbrew International GmbH 8,441,666  53.56%   8,441,665  53.57%
    Ambrew S.A.R.L. 1,287,700  8.17%   1,287,671  8.17%
    Fundação Zerrenner 1,609,987  10.21%   1,609,987  10.22%
    Market (free float) 4,252,857  26.98%   4,386,859  27.84%
    Treasury shares 169,429  1.07%   31,475  0.20%
      15,761,639  100.00%   15,757,657  100.00%

     

      06/30/2025   06/30/2024
      Thousands of common shares Thousands of Real   Thousands of common shares Thousands of Real
    Opening balance 15,757,657  58,226,036    15,753,833  58,177,929 
    Capital increase (i) 3,982  49,660    3,824  48,107 
    Balance at the end of the period 15,761,639  58,275,696    15,757,657  58,226,036 

     

    (i) Capital increase related to the issue of shares, under Company’s share-based payment programs.

     

    15.2 Capital reserves

     

      Capital Reserves   
      Treasury shares  Share Premium  Other capital reserves  Share-based Payments   Total 
    Balance at January 1, 2024 (1,011,949) 53,662,811  700,898  2,127,804  55,479,564 
    Gains/(losses) of controlling interest -    -    -    1,958  1,958 
    Share buybacks, results from treasury shares, and share-based payments (328,202) -    -    127,142  (201,060)
    Balance at June 30, 2024 (1,340,151) 53,662,811  700,898  2,256,904  55,280,462 

     

      Capital Reserves   
      Treasury shares  Share Premium  Other capital reserves  Share-based Payments   Total 
    Balance at January 1, 2025 (1,332,743) 53,662,811  700,898  2,305,444  55,336,410 
    Share buybacks, results from treasury shares, and share-based payments (1,740,750) -    -    72,094  (1,668,656)
    Balance at June 30, 2025 (3,073,493) 53,662,811  700,898  2,377,538  53,667,754 
     

    AMBEV S.A.

     

    15.2.1 Share buyback and treasury shares results

     

    Treasury shares represent the Company’s own issued shares which have been reacquired by the Company, and the results of treasury shares relate to gains and losses on share-based payment transactions and others. The changes in treasury shares are as follow:

     

      Acquisition/(realization of shares)   Results from treasury shares   Total treasury shares
      Thousands of shares   Thousands of Brazilian Reais   Thousands of shares   Thousands of Brazilian Reais
    Balance at January 1, 2024 4,384    (63,095)   (948,854)   (1,011,949)
    Changes during the year 27,091    (325,274)   (2,928)   (328,202)
    Balance at June 30, 2024 31,475    (388,369)   (951,782)   (1,340,151)

     

      Acquisition/(realization of shares)   Results from treasury shares   Total treasury shares
      Thousands of shares   Thousands of Brazilian Reais   Thousands of shares   Thousands of Brazilian Reais
    Balance at January 1, 2025 29,807    (365,626)   (967,117)   (1,332,743)
    Changes during the year 139,622    (1,746,830)   6,080    (1,740,750)
    Balance at June 30, 2025 169,429    (2,112,456)   (961,037)   (3,073,493)

     

    15.2.2 Share-based payment

    Different share-based payment programs allow the Group’s senior Management to acquire shares in the Company (note 21 – Share-based payments). The share-based payment reserve recorded a charge of R$206,107 on June 30, 2025 (R$187,704 at June 30, 2024).

     

    15.3 Net income reserves

     

      Profit reserves  
      Investment reserve  Legal reserve   Fiscal incentives Total
    Balance at January 1, 2024 25,786,098  4,456  17,399,286  43,189,840 
    Balance at June 30, 2024 25,786,098  4,456  17,399,286  43,189,840 

     

      Profit reserves  
      Investment reserve  Legal reserve   Fiscal incentives Total
    Balance at January 1, 2025 36,125,152  4,456  17,507,411  53,637,019 
    Dividends (496,600) -    -    (496,600)
    Balance at June 30, 2025 35,628,552  4,456  17,507,411  53,140,419 

     

    There was no change in profit reserves in the second quarter of 2024 and of 2025.

     

    15.3.1 Tax incentives

     

    The tax incentives recognized by the Company in its net equity, in the profit reserves account, relate to industrial development programs that aim at the fostering of employment generation, increasing of regional decentralization, in addition to complementing and diversifying the industrial bases of some regions and states in Brazil. In these states, the grace periods and terms are set out in normative acts issued by the respective states, and when there are conditions for obtaining these grants, they are under the Company’s control. The tax treatment of states incentives complies with the provisions of current federal, state and municipal legislation, in particular Complementary Federal Law No. 160/2017 and by Convênio CONFAZ No. 190/2017. With the revocation of Article 30 of Federal Law No. 12,973/14 by Federal Law No. 14,789/23, the State tax incentives under the nature of presumed ICMS credits ceased to be allocated to the tax incentive reserve, starting from 2024. The other federal and state tax incentives continue to be recognized as reserve.

     

     

    AMBEV S.A.

     

    15.3.2 Interest on capital/dividends

     

    Event Approval Type Date of payment Year Type of share Amount per share Total amount
    Board of Directors’ Meeting 02/25/2025 Dividends 04/04/2025 2025 ON 0.1276 1,997,499 
    Board of Directors’ Meeting 7/5/2025 Dividends 07/07/2025 2025 ON 0.1280 2,000,739 
                  3,998,238 

     

    Distribution dividends–February/2025 resolution: on meeting held on February 25, 2025, the Board of Directors approved the distribution of dividends at a rate of R$0.1276 per share of the Company, based on the available balances in the balance sheet of January 31, 2025, which were treated as part of the mandatory minimum dividends for the 2025 fiscal year and the remainder was allocated to the Investments Reserve constituted in previous fiscal years. The payment of dividends was made on April 04, 2025.

     

    Distribution dividends–May/2025 resolution: on meeting held on May 07, 2025, the Board of Directors approved the distribution of dividends at a rate of R$0.1280 per share of the Company, based on the available balances in the balance sheet of March 31, 2025, which were treated as part of the mandatory minimum dividends for the 2025 The payment of dividends was made on July 07, 2025.

     

    AMBEV S.A.

     

    15.4 Carrying value adjustments

     

      Carrying value adjustments  
      Translation reserves Cash flow hedge Actuarial gains/ (losses) Gains/(losses) of non-controlling interest’s share Other movements Business combination Accounting adjustments for transactions between shareholders Total
    Balance at January 1, 2024 (2,458,382) 697,825  (678,235) (81,172) (64,503) 156,091  (75,449,667) (77,878,043)
    Comprehensive income:                
    Gains/(losses) on cumulative translation adjustments [CTA] 5,112,045  -    -    -    -    -    -    5,112,045 
    Cash flow hedges -    244,864  -    -    -    -    -    244,864 
    Actuarial gains/(losses) -    -    888  -    -    -    -    888 
    Total comprehensive income  5,112,045  244,864  888  -    -    -    -    5,357,797 
    Gains/(losses) of controlling interest 385,670  (578) (1,174) 128,467  -    -    -    512,385 
    Taxes on deemed dividends -    -    -    -    (7,089) -    -    (7,089)
    Balance at June 30, 2024 3,039,333  942,111  (678,521) 47,295  (71,592) 156,091  (75,449,667) (72,014,950)

     

      Carrying value adjustments  
      Translation reserves Cash flow hedge Actuarial gains/ (losses) Gains/(losses) of non-controlling interest’s share Other movements Business combination Accounting adjustments for transactions between shareholders Total
    Balance at January 1, 2025 6,121,951  1,248,882  (602,521) 74,007  (94,246) 156,091  (75,461,490) (68,557,326)
    Comprehensive income:                
    Gains/(losses) on cumulative translation adjustment [CTA] (7,030,017) -    -    -    -    -    -    (7,030,017)
    Cash flow hedges -    (1,346,338) -    -    -    -    -    (1,346,338)
    Actuarial gains/(losses) -    -    (1,000) -    -    -    -    (1,000)
    Total comprehensive income  (7,030,017) (1,346,338) (1,000) -    -    -    -    (8,377,355)
    Gains/(losses) of controlling interest -    -    -    1,825  -    -    -    1,825 
    Taxes on deemed dividends -    -    -    -    (4,196) -    -    (4,196)
    Balance at June 30, 2025 (908,066) (97,456) (603,521) 75,832  (98,442) 156,091  (75,461,490) (76,937,052)
     

    AMBEV S.A.

     
    16.SEGMENT REPORTING

     

    (a)Reportable segments six-month period ended on June 30,:
      Brazil CAC Latin America – South Canada Consolidated
      2025 2024 2025 2024 2025 2024 2025 2024 2025 2024
                         
    Net sales 23,276,147  22,927,426  5,441,498  4,894,691  8,831,284  8,010,571  5,038,643  4,487,824  42,587,572  40,320,512 
    Cost of sales (11,588,020) (11,604,180) (2,502,219) (2,304,286) (4,777,639) (4,277,792) (2,123,977) (1,932,716) (20,991,855) (20,118,974)
    Gross profit 11,688,127  11,323,246  2,939,279  2,590,405  4,053,645  3,732,779  2,914,666  2,555,108  21,595,717  20,201,538 
    Distribution expenses (3,031,349) (3,129,226) (444,846) (426,021) (1,128,412) (1,052,159) (852,435) (834,082) (5,457,042) (5,441,488)
    Sales and marketing expenses (2,404,919) (2,407,814) (382,630) (357,809) (873,188) (864,844) (582,096) (465,204) (4,242,833) (4,095,671)
    Administrative expenses (1,819,957) (1,802,274) (237,761) (214,251) (485,450) (434,355) (372,026) (332,518) (2,915,194) (2,783,398)
    Other operating income/(expenses) 1,175,584  1,105,611  (2,900) 6,171  16,382  (7,589) 11,987  8,420  1,201,053  1,112,613 
    Exceptional items (17,299) (6,837) (4,824) (4,160) (34,397) (4,791) (16,055) (13,508) (72,575) (29,296)
    Income from operations 5,590,187  5,082,706  1,866,318  1,594,335  1,548,580  1,369,041  1,104,041  918,216  10,109,126  8,964,298 
    Net financial results                 (1,830,367) (1,022,167)
    Share of results of associates and joint ventures                 (2,738) (35,022)
    Income before income tax                 8,276,021  7,907,109 
    Income tax expenses                 (1,680,806) (1,651,039)
    Net income                 6,595,215  6,256,070 
                         
    Acquisitions of property, plant and equipment 1,402,121  1,289,070  188,337  247,124  233,738  404,022  92,158  103,770  1,916,354  2,043,986 

     

     

    AMBEV S.A.

     

    (continued)

     

      Brazil CAC Latin America – South Canada Consolidated
      06/30/2025 12/31/2024 06/30/2025 12/31/2024 06/30/2025 12/31/2024 06/30/2025 12/31/2024 06/30/2025 12/31/2024
                         
    Segment assets 57,398,142  57,775,680  15,093,285  16,742,086  23,273,536  28,247,805  17,555,959  18,394,281  113,320,922  121,159,852 
    Inter-segment eliminations                 (3,351,641) (4,607,706)
    Non-segmented assets (i)                 32,188,262  45,955,803 
    Total assets                 142,157,543  162,507,949 
                         
    Segment liabilities 25,407,205  34,429,339  5,695,605  6,814,181  5,233,053  9,146,093  4,554,521  4,976,576  40,890,384  55,366,189 
    Inter-segment eliminations                 (3,351,632) (4,607,698)
    Non-segmented liabilities (i)                 104,618,791  111,749,458 
    Total liabilities                 142,157,543  162,507,949 

     

    (i) The balance of non-segmented assets relate refers mainly to cash and cash equivalents, taxes and investments. The balance of non-segmented liabilities refers mainly to equity, taxes and derivatives.

     

    Non-current assets attributed to Brazil (country of domicile of the Company) and to Canada amounted to R$44,501,839 and R$14,782,864, respectively at June 30, 2025 (R$44,725,285 and R$16,131,204, respectively, at December 31, 2024). The net revenue attributable to the Company's operations in Argentina amounted to R$4,394,929 in the six-month period ended June 30, 2025 (R$4,700,052 as of June 30, 2024), and the segmented non-current assets related to the same country totaled R$10,756,346 for the same period ended June 30, 2025 (R$12,576,758 as of December 31, 2024).

     

    AMBEV S.A.

     
    (b)Reportable segments – three-month period ended on June 30,:

     

      Brazil CAC Latin America – South Canada Consolidated
      2025 2024 2025 2024 2025 2024 2025 2024 2025 2024
                         
    Net sales 11,020,777  11,215,508  2,784,574  2,579,989  3,295,172  3,608,650  2,989,671  2,640,068  20,090,194  20,044,215 
    Cost of sales (5,596,371) (5,654,302) (1,244,640) (1,216,596) (1,943,746) (2,086,939) (1,261,366) (1,102,143) (10,046,123) (10,059,980)
    Gross profit 5,424,406  5,561,206  1,539,934  1,363,393  1,351,426  1,521,711  1,728,305  1,537,925  10,044,071  9,984,235 
    Distribution expenses (1,452,275) (1,513,462) (221,114) (225,692) (456,678) (559,285) (450,280) (452,039) (2,580,347) (2,750,478)
    Sales and marketing expenses (1,273,405) (1,301,291) (193,938) (188,869) (375,472) (464,506) (330,091) (256,481) (2,172,906) (2,211,147)
    Administrative expenses (908,143) (980,634) (124,208) (119,737) (214,674) (203,709) (179,322) (146,950) (1,426,347) (1,451,030)
    Other operating income/(expenses) 590,325  517,106  (11,478) 802  4,557  929  2,451  747  585,855  519,584 
    Exceptional items (7,598) (2,028) (2,311) (3,339) (25,244) (3,155) (16,055) (3,205) (51,208) (11,727)
    Income from operations 2,373,310  2,280,897  986,885  826,558  283,915  291,985  755,008  679,997  4,399,118  4,079,437 
    Net financial results                 (973,985) (616,223)
    Share of results of associates and joint ventures                 (5,457) (31,452)
    Income before income tax                 3,419,676  3,431,762 
    Income tax expenses                 (629,110) (979,874)
    Net income                 2,790,566  2,451,888 

     

    The net revenue attributable to the Company's operations in Argentine amount to R$1,377,488 billion in the three-month period ended June 30, 2025 (R$2,142,509 billion in the three-month period ended June 30, 2024).

     

    AMBEV S.A.

     
    (c)Additional information – by business unit – six and three-month periods ended on June 30,:

     

      Six-month period ended June 30:   Three-month period ended June 30:
      Brazil   Brazil
      Beer NAB Total    Beer NAB Total 
      2025 2024 2025 2024 2025 2024   2025 2024 2025 2024 2025 2024
                               
    Net sales 18,990,371  18,998,921  4,285,776  3,928,505  23,276,147  22,927,426    8,989,614  9,311,412  2,031,163  1,904,096  11,020,777  11,215,508 
    Cost of sales (9,120,785) (9,427,629) (2,467,235) (2,176,551) (11,588,020) (11,604,180)   (4,413,494) (4,615,153) (1,182,877) (1,039,149) (5,596,371) (5,654,302)
    Gross profit 9,869,586  9,571,292  1,818,541  1,751,954  11,688,127  11,323,246    4,576,120  4,696,259  848,286  864,947  5,424,406  5,561,206 
    Distribution expenses (2,360,410) (2,531,669) (670,939) (597,557) (3,031,349) (3,129,226)   (1,138,921) (1,235,661) (313,354) (277,801) (1,452,275) (1,513,462)
    Sales and marketing expenses (2,188,943) (2,171,366) (215,976) (236,448) (2,404,919) (2,407,814)   (1,157,287) (1,176,806) (116,118) (124,485) (1,273,405) (1,301,291)
    Administrative expenses (1,593,956) (1,566,929) (226,001) (235,345) (1,819,957) (1,802,274)   (794,596) (857,406) (113,547) (123,228) (908,143) (980,634)
    Other operating income/(expenses) 920,614  897,452  254,970  208,159  1,175,584  1,105,611    459,781  422,397  130,544  94,709  590,325  517,106 
    Exceptional items (17,299) (6,837) -    -    (17,299) (6,837)   (7,598) (2,028) -    -    (7,598) (2,028)
    Income from operations 4,629,592  4,191,943  960,595  890,763  5,590,187  5,082,706    1,937,499  1,846,755  435,811  434,142  2,373,310  2,280,897 
    Net financial results         (972,154) (696,131)           (469,695) (244,958)
    Share of results of associates and joint ventures         (2,771) (33,901)           (5,457) (30,500)
    Income before income tax         4,615,262  4,352,674            1,898,158  2,005,439 
    Income tax expenses         (290,019) (315,576)           (93,000) (397,039)
    Net income         4,325,243  4,037,098            1,805,158  1,608,400 
     

    AMBEV S.A.

     
    17.NET SALES

     

    In compliance with Brazilian Federal Law No 6,404/76, Company discloses the reconciliation between gross and net sales presented in the consolidated income statement. The revenue figures for each operational segment are disclosed in note 16 – Segment reporting.

     

      six-month period ended:   Three-month period ended:
      06/30/2025 06/30/2024   06/30/2025 06/30/2024
               
    Gross sales 63,301,087  60,305,095    29,647,661  29,950,562 
    Excise duty (13,187,360) (12,446,232)   (6,247,115) (6,213,590)
    Discounts (7,526,155) (7,538,351)   (3,310,352) (3,692,757)
    Total 42,587,572  40,320,512    20,090,194  20,044,215 

     

    At June 30, 2025 the Company recognized R$735,523 in tax incentives (R$674,223 at June 30, 2024). These are government grants in the nature of effective tax collection, which were recognized in the operating net revenue.

     

    Additionally, in the three-month period ended June 30, 2025, are recognized R$351,479 (R$368,083 in the three-month period ended June 30, 2024) under the same nature and accounting classification.

     

    18.OTHER OPERATING INCOME/(EXPENSES)

     

      six-month period ended:   Three-month period ended:
      06/30/2025 06/30/2024   06/30/2025 06/30/2024
               
    Government grants and gains on subsidies loans 873,196  821,678    416,571  436,065 
    (Additions to)/reversals of provisions (74,772) (11,901)   (7,751) (5,809)
    Gains/(losses) on disposals of property, plant and equipment, intangible assets and the operations of associates 62,078  41,889    29,488  21,206 
    Other operating income/(expenses), net 340,551  260,947    147,547  68,122 
    Total 1,201,053  1,112,613    585,855  519,584 

     

    19.EXCEPTIONAL ITEMS

     

      six-month period ended:   Three-month period ended:
      06/30/2025 06/30/2024   06/30/2025 06/30/2024
    Restructuring (i) (72,405) (28,970)   (51,038) (11,401)
    Effects of the application of IAS 29 (hyperinflation) (170) (326)   (170) (326)
    Total (72,575) (29,296)   (51,208) (11,727)

     

    (i) The restructuring expenses primarily relate to organizational alignments as a result of operational improvements, sizing and digitalization efforts of the Group.

     

    AMBEV S.A.

     
    20.FINANCIAL RESULTS

     

      six-month period ended:   Three-month period ended:
      06/30/2025 06/30/2024   06/30/2025 06/30/2024
    Finance income          
    Income from cash and cash equivalents 591,566  729,736    249,477  345,352 
    Income from debt securities 80,568  37,810    45,649  28,286 
    Income from other receivables (i) 389,506  333,415    202,327  141,723 
    Other finance income 282,473  29,520    163,112  15,370 
    Total finance income 1,344,113  1,130,481    660,565  530,731 
               
    Finance expenses          
    Interest on accounts payable present value adjustment (545,470) (614,493)   (273,316) (282,353)
    Interest on bank debts and tax incentives (87,602) (93,227)   (43,320) (46,267)
    Interest on provisions for disputes and litigation (87,911) (94,046)   (35,604) (49,668)
    Interest on leases (121,559) (78,738)   (63,685) (40,646)
    Interest on pension plans (55,226) (53,514)   (27,405) (27,004)
    Other interest expenses (ii) (256,445) (261,212)   (124,567) (128,864)
    Losses on hedging instruments (iii) (554,679) (343,139)   (276,288) (147,957)
    Taxes on financial transactions (119,809) (100,876)   (50,829) (45,584)
    Bank guarantee expenses and surety bond premiums (170,407) (116,621)   (101,231) (59,280)
    Other finance expenses (iv) (133,759) (161,679)   (82,420) (77,453)
    Total finance expenses (2,132,867) (1,917,545)   (1,078,665) (905,076)
               
    Effects of the application of IAS 29 (hyperinflation) (26,227) (144,205)   (28,420) (184,921)
    Exchange differences, net (1,015,386) (90,898)   (527,465) (56,957)
    Other net financial results (1,041,613) (235,103)   (555,885) (241,878)
               
    Net financial results (1,830,367) (1,022,167)   (973,985) (616,223)

     

     

    (i) Refers mainly to the monetary updates to taxes to be recovered.

     

    (ii) Includes, among others, interest related to the financing of tax payments, under the 2017 Special Tax Regularization Program (“PERT”).

     

    (iii) Refers to the forward element, which can be separated and excluded from the designation of a financial instrument as a hedge instrument, according to IFRS 9- Financial Instruments.

     

    (iv) In some jurisdictions where the Group operates, there are additional costs for acquiring foreign currency, used for payments to some suppliers, as well as for the remittance of earnings to the parent companies.

     

    Interest expenses are presented net of the effects of derivative financial instruments hedging the Company’s interest rate risk (see also note 22- Financial instruments and risks).

     

    21.SHARE-BASED PAYMENTS

     

    Currently, the Company has two plans for share-based payment programs: (i) the Stock Option Plan, approved at the Extraordinary General Meeting of July 30, 2013 (the “Stock Option Plan”); and (ii) the Share-based Plan approved at the Extraordinary General Meeting of April 29, 2016, as amended at the Extraordinary General Meeting of April 24, 2020 (“Share-Based Plan”). Each plan may periodically issue different stock options, restricted stock units (RSUs) and performance stock units (PSUs) programs. These programs allow the Group employees and senior Management members nominated by the Board of Directors and People Committee to acquire, through the exercise of stock options, or receive shares in the Company.

     

    AMBEV S.A.

     

    21.1 Share-Based Plan

     

    During the six-month period, the Company granted 15,146 thousand restricted and performance shares under the Share-Based Plan (6,787 thousand in June 30, 2024), representing a fair value of approximately R$185,063 in June 30, 2025 (R$85,384 in June 30, 2024).

     

    The total number of shares granted to employees under the Share-Based Plan, and which will be delivered in the future based on the fulfilment of certain conditions, is set out below:

     

    Restricted and performance stock units

     

    Thousand restricted shares 06/30/2025   06/30/2024
           
    Restricted and performance stocks outstanding at January 120,417    118,996 
    New restricted and performance stocks during the period 15,146    6,787 
    Restricted and performance stocks vested during the period (10,692)   (3,923)
    Restricted and performance stocks forfeited during the period (4,184)   (2,490)
    Restricted and performance stocks outstanding at the end of the period 120,687    119,370 

     

    21.2 Options Plan

     

    Stock options have not neither been granted nor exercised during the periods ended on June 30, 2025, and June 30, 2024. The total number of outstanding stock options is as follows:

     

    Thousand options 06/30/2025   06/30/2024
           
    Options outstanding at January 1 72,466    87,961 
    Options forfeited during the period (937)   (1,082)
    Options outstanding at the end of the period 71,529    86,879 

     

    In June 30, 2025the exercise prices of the outstanding options range from R$16.34 (R$15.95 at June 30, 2024) to R$22.40 (R$32.91 at June 30, 2024), and the remaining exercise period for these options is up to 53.00 months. Of the 71,529 thousand outstanding options (86,879 thousand at June 30, 2024), 71,529 thousand options were vested in June 30, 2025 (68,977 thousand in June 30, 2024).

     

    The weighted average exercise price of the options is as follows:

     

    In R$ per share 06/30/2025   06/30/2024
           
    Options outstanding on January 1 18.26    18.86 
    Options forfeited during the period 18.23    18.13 
    Options outstanding at the end of the period 19.44    18.87 
    Options exercisable at the end of the period 19.44    19.08 

     

    The Company carries out periodic share buybacks when necessary to meet the need for shares to be delivered under the above Plans.

     

    21.3 Expenses related to share-based payments

     

    The share-based payments transactions described above generated an expense of R$208,730 on June 30, 2025 (R$187,706 on June 30, 2024), which was recorded under administrative expenses.

     

    AMBEV S.A.

     
    22.FINANCIAL INSTRUMENTS AND RISKS

     

    22.1 Categories of financial instruments

     

    The financial instruments held by the Company and its subsidiaries are managed through operational strategies and internal controls to assure liquidity, profitability, and transaction security. Transactions involving financial instruments are regularly reviewed to assess the effectiveness of the risk exposure that Management intends to cover (including foreign exchange, and interest rate risk, among others).

     

    The table below shows the consolidated financial instruments recognized in the financial statements, segregated by category:

     

     Financial instrument items  06/30/2025 12/31/2024
    Assets    
    Amortized cost    
    Cash and cash equivalents (note 5.1) 16,404,025  28,595,666 
    Trade receivables excluding prepaid expenses  7,436,570  8,140,218 
    Investment securities (note 5.2) 117,804  255,959 
    Subtotal 23,958,399  36,991,843 
    Fair value through profit or loss    
    Investment securities (note 5.2) 1,106,252  1,170,496 
    Derivatives hedges (note 22.2) 266,348  1,218,587 
    Subtotal 1,372,600  2,389,083 
    Total assets 25,330,999  39,380,926 
         
    Liabilities    
    Amortized cost    
    Trade payables (note 12) 20,203,635  25,551,228 
    Interest-bearing loans and borrowing (note 13) 3,157,764  3,452,728 
    Other liabilities 2,887,905  3,044,314 
    Subtotal 26,249,304  32,048,270 
    Fair value through profit or loss    
    Put options granted on subsidiaries (i) 1,137,851  1,184,177 
    Derivatives hedges (note 22.2) 930,743  211,441 
    Other liabilities 259,735  300,519 
    Subtotal 2,328,329  1,696,137 
    Total liabilities 28,577,633  33,744,407 

     

    (i) Put options granted on subsidiaries: the Company constituted a liability related to the acquisition of a non-controlling interest in the operations in the Dominican Republic. This financial instrument denominated Dominican Pesos for Tranche B. The instrument is recorded by an entity whose functional currency is the Brazilian Real. The Company assigned this financial instrument as a hedging instrument for a portion of its net assets located in subsidiaries whose functional currency is either the US Dollar or the Dominican Peso, in such a manner that the hedge result can be recorded in other comprehensive income of the group, in line with the results from the hedged items.

     

    At June 30, 2025 and December 31, 2024, the Company did not have any financial assets classified as at fair value through other comprehensive income.

     

     

    AMBEV S.A.

     

    22.2 Derivative financial instruments

     

    Transactions protected by derivative financial instruments in accordance with the Financial Risk Management Policy

     

                  Six-month period ended: 06/30/2025   Three-month period ended: 06/30/2025
              Fair Value   Gains/(losses)   Gain / (Losses)
    Hedge position   Risk Notional   Assets Liabilities   Financial results Operational result Equity   Financial results Operational result Equity
          Forward element Spot element Hedge accounting effect   Forward element Spot element Hedge accounting effect
                                 
    Cost     20,074,392    265,797  (924,959)   (552,579) 693,739  (1,072,517)   (298,285) 110,647  (476,066)
        Commodities 5,173,572    186,873  (173,765)   (45,394) (42,468) 68,071    (4,505) (72,120) 38,223 
        US Dollars 14,900,820    78,924  (751,194)   (507,185) 736,207  (1,140,588)   (293,780) 182,767  (514,289)
                                 
    Imports of fixed assets     130,548    382  (3,793)   (566) 2,537  (7,231)   29  432  (4,568)
        US Dollars 130,548    382  (3,793)   (566) 2,537  (7,231)   29  432  (4,568)
                                 
    Expenses     68,770    169  (1,991)   (359) 1,180  (3,891)   (113) 406  (2,474)
        US Dollars 68,770    169  (1,991)   (359) 1,180  (3,891)   (113) 406  (2,474)
    Balance at end of the period     20,273,710    266,348  (930,743)   (553,504) 697,456  (1,083,639)   (298,369) 111,485  (483,108)

     

     

    AMBEV S.A.

     
          12/31/2024   Six-month period ended: 06/30/2024   Three-month period ended: 06/30/2024
              Fair Value   Gains/(losses)   Gain / (Losses)
    Hedge position   Risk Notional   Assets Liabilities   Financial results Operational result Equity   Financial results Operational result Equity
          Forward element Spot element Hedge accounting effect   Forward element Spot element Hedge accounting effect
                                 
    Cost     16,309,171    1,202,356  (211,364)   (331,264) 24,479  201,640    (131,087) 133,520  1,026,279 
        Commodities 5,026,998    127,867  (204,113)   (165,779) (50,129) (35,883)   (91,686) 23,539  120,012 
        US Dollars 11,282,173    1,074,489  (6,891)   (167,393) 73,837  237,640    (40,178) 109,739  906,625 
        Euros -      -    -      (156) 254  141    (62) 134  63 
        Mexican Pesos -      -    (360)   2,064  517  (258)   839  108  (421)
                                 
    Imports of fixed assets     207,906    10,121  (71)   (3,337) 3,994  10,039    (3,853) 2,349  4,881 
        US Dollars 207,906    10,121  (71)   (3,337) 3,994  10,039    (3,853) 2,349  4,881 
                                 
    Expenses     57,532    3,451  -      (1,080) 996  2,575    746  592  1,558 
        US Dollars 57,532    3,451  -      (1,080) 996  2,575    746  592  1,558 
                                 
    Financial assets     -      2,659  -      2,215  -    -      2,215  -    -   
        US Dollars -      2,659  -      2,215  -    -      2,215  -    -   
    Balance at end of the period     16,574,609    1,218,587  (211,441)   (333,466) 29,469  214,254    (131,979) 136,461  1,032,718 

     

    As disclosed in its accounting policy, the forward element, which can be separated and excluded from the designation of the financial instrument as a hedging instrument, is recognized in the financial result, in accordance with IFRS 9 - Financial Instruments.

     

    AMBEV S.A.

     

    22.2.1 Instrument maturity

     

    At June 30, 2025, the Notional and Fair Value amounts per instrument and maturity were as follow:

     

        Notional Value
    Hedge position Risk 2025 2026 Total
             
    Cost   11,239,182  8,835,210  20,074,392 
       Commodities  3,129,023  2,044,549  5,173,572 
       US Dollars  8,110,159  6,790,661  14,900,820 
             
    Imports of fixed assets   77,601  52,947  130,548 
      US Dollars  77,601  52,947  130,548 
             
    Expenses   24,872  43,898  68,770 
      US Dollars  24,872  43,898  68,770 
        11,341,655  8,932,055  20,273,710 

     

        Fair Value
    Hedge position Risk 2025 2026 Total
             
    Costs   (502,916) (156,246) (659,162)
      Commodities (14,241) 27,349  13,108 
      US Dollars (488,675) (183,595) (672,270)
             
    Imports of fixed assets   (2,338) (1,073) (3,411)
      US Dollars (2,338) (1,073) (3,411)
             
    Expenses   (799) (1,023) (1,822)
      US Dollars (799) (1,023) (1,822)
        (506,053) (158,342) (664,395)

     

    22.2.2 Margins pledged as guarantees

     

    In order to comply with the guarantee’s requirements regarding derivative exchanges and/or counterparties to certain operations with derivative financial instruments, at June 30, 2025, the Group held R$215,150 financial investments with high liquidity or in cash, classified as cash and cash equivalents and investment securities (R$165,736 at December 31, 2024).

     

     

    AMBEV S.A.

     

    22.3 Classification of financial instruments

     

      06/30/2025   12/31/2024
      Level 1 Level 2 Level 3 Total   Level 1 Level 2 Level 3 Total
    Financial assets                  
    Investment securities 1,106,252  -    -    1,106,252    1,170,496  -    -    1,170,496 
    Derivatives assets at fair value through profit and loss -    -    -    -      2,659  -    -    2,659 
    Derivatives – operational hedges 95,839  170,509  -    266,348    21,274  1,194,654  -    1,215,928 
      1,202,091  170,509  -    1,372,600    1,194,429  1,194,654  -    2,389,083 
    Financial liabilities                  
    Put options granted on subsidiaries -    -    1,137,851  1,137,851    -    -    1,184,177  1,184,177 
    Other liabilities -    -    259,735  259,735    -    -    300,519  300,519 
    Derivatives – operational hedges 70,661  860,082  -    930,743    52,232  159,209  -    211,441 
      70,661  860,082  1,397,586  2,328,329    52,232  159,209  1,484,696  1,696,137 

     

    There were no transfers of assets and liabilities among fair value hierarchy Levels 1, 2, and 3 during the periods presented.

     

    22.3.1 Financial instruments level 3

     

    PUT CND

     

    In line with the Shareholders' Agreement of Tenedora CND S.A. ("Tenedora”) – holding company headquartered in the Dominican Republic which owns almost the entire share capital of CNDominicana – executed between the Company and E. León Jimenes, S.A. (“ELJ”), ELJ is the owner of 2.89% of the shares of Tenedora, and has a put option for such remaining interest, corresponding to Tranche B as provided in the Agreement. This put option may be exercised by ELJ starting from 2026 (or prior to that date in the event of a change of control of Tenedora or the sale of all or substantially all of its assets). The Company, on the other hand, has a call option over the Tranche B shares exercisable starting from 2029.

     

    At June 30, 2025, the Tranche B shares held by ELJ, were valued at R$1,137,851 (R$1,184,177 at December 31, 2024). The fair value of Tranche B was calculated based on the EBITDA multiple defined in the contract, less net debt, brought to its present value, calculated using standard valuation techniques (the present value of the principal amount and future interest, discounted by the local currency’s WACC rate at the calculation date). The criteria used are based on market information from reliable sources and categorized within “Level 3”.

     

    Contingent consideration on acquisitions of G&W and Banded Peak

     

    On January 2020, the Company’s subsidiary in Canada, Labatt Brewing Company Limited, acquired G&W Distilling Inc., a company with a portfolio of ready-to-drink alcoholic beverages. In the same month, Labatt also purchased the shares of Banded Peak Brewing Ltd., a Canadian craft brewery.

     

    A portion of the purchase prices of both transactions included contingent considerations based on the future performances of G&W and Banded Peak after the acquisition. During the first quarter of 2025, Labatt settled the total outstanding amount of the contingent consideration owed to Banded Peak; in addition, the balance reduction was also due to the change in the fair value of the contingent consideration owed to G&W. Thus, in June 30, 2025, the fair value of the G&W contingent consideration was R$259,735 (R$300,519 in December 31, 2024, considering the Banded Peak contingent consideration as well). Management expects that the G&W contingent consideration will be settled during the fiscal year 2025 as well.

     

    AMBEV S.A.

     

    22.3.2 Reconciliation of changes in the liabilities categorized at Level 3

     

    Financial liabilities at December 31, 2024 1,484,696 
    Settlement of contingent consideration (25,571)
    Total gains and losses during the period (61,539)
       Losses/(gains) recognized in net income 66,434 
       Losses/(gains) recognized in equity (127,973)
    Financial liabilities at June 30, 2025 1,397,586 

     

    22.4 Risk management

     

    The Company is exposed to foreign currency, interest rate, commodity price, liquidity, and credit risk in the ordinary course of its business. The Company analyzes each of these risks both individually and on a consolidated basis, to define strategies to manage the economic impact on risks in line with its Financial Risk Management Policy.

     

    22.4.1 Market risk

     

    22.4.1.1 Interest rate risk: represents of the possibility that the Company may incur losses due to fluctuations in interest rates, which may increase the financial expenses on its financial liabilities, and/or decrease the financial income from its financial assets, as well as negatively impacting the fair value of financial assets measured at fair value. To mitigate this risk the Company applies a dynamic interest rate hedging approach, whereby the target mix between fixed and floating rate debt is reviewed periodically. The purpose of the Company’s policy is to achieve an optimal balance between the cost of funding and the volatility of financial results, considering market conditions. The Company’s overall business strategy is reviewed periodically.

     

    The table below demonstrates the exposure of the Company and its subsidiaries to debts and respective weighted interest rates. As June 30, 2025, the Company and its subsidiaries did not hold hedge positions to the exposure described below:

     

      06/30/2025   12/31/2024
      Risk   Risk
      Interest rate Amount in Brazilian Real   Interest rate Amount in Brazilian Real
    Brazilian Reais 10.7% 2,083,382    10.2% 2,245,099 
    Other 13.8% 411,953    13.0% 510,194 
    US Dollars 3.6% 15,094    8.0% 3,786 
    Canadian Dollars 5.7% 378,812    5.8% 439,367 
    Pre-fixed interest rate    2,889,241      3,198,446 
               
               
    Brazilian Reais 7.6% 268,523    7.8% 254,282 
    Post - fixed interest rate    268,523      254,282 

     

     

    AMBEV S.A.

     

     

    Sensitivity analysis

     

    The Company mitigates the bulk of the risks arising from non-derivative financial assets and liabilities using derivative financial instruments. In this context, the Company has identified the main risk factors that could lead to losses on these derivative financial instruments and has developed a sensitivity analysis based on three scenarios which could impact the Company’s future results and/or cash flow.

     

    The sensitivity analysis of exchange differences and commodity price variations is as follows:

     

              06/30/2025
    Transaction Risk Fair Value Probable scenario Adverse scenario Remote scenario
               
    Commodities hedges Increases in commodities price 13,108  53,680  1,306,501  2,599,894 
    Input purchases (13,108) (66,523) (1,340,018) (2,666,928)
    Foreign exchange hedges Foreign currency increases (672,270) (520,369) 3,052,935  6,778,140 
    Input purchases 672,270  502,308  (3,532,283) (7,736,835)
    Cost effects   -    (30,904) (512,865) (1,025,729)
               
    Foreign exchange hedges Foreign currency increases (3,411) (2,997) 29,226  61,863 
    Capex purchases 3,411  2,877  (40,959) (85,329)
    Fixed asset effects   -    (120) (11,733) (23,466)
               
    Foreign exchange hedges Foreign currency increases (1,822) (1,556) 15,371  32,563 
    Expenses 1,822  615  (38,017) (77,857)
    Results of expense effects   -    (941) (22,646) (45,294)
        -    (31,965) (547,244) (1,094,489)

     

    22.4.1.3 Commodity risk: A significant portion of the Company’s inputs are made up of commodities, which have historically seen substantial price fluctuations. The Company's Policy establishes that entering into hedges is an appropriate way to protect the Company against unforeseen fluctuations in prices and foreign currency. The Company therefore uses both fixed price purchasing contracts and derivative financial instruments to minimize its exposure to volatility in the commodity prices of aluminum, sugar, wheat, corn and paraxylene. These derivative financial instruments have been designated as cash flow hedges.

     

    22.4.2 Credit risk

     

    The carrying amounts of cash and cash equivalents, investment securities, trade receivables excluding prepaid expenses, recoverable taxes and derivative financial instruments are disclosed net of provisions for impairment, and represent the maximum exposure to credit risk at June 30, 2025. At June 30, 2025, there was no concentration of credit risk on any counterparty in excess of the limits established by the Company’s Credit Risk Policy. The counterparty risk is reassessed on a quarterly basis.

     

    Customers

    A substantial portion of the Company’s sales is made to distributors, supermarkets, and retailers, through a broad distribution network. Credit risk is mitigated by the large number of customers and by the control procedures used to monitor risk. Historically, the Company has not incurred significant losses on receivables from customers.

     

     

    AMBEV S.A.

     

     

    Investments

    In order to minimize the credit risk on its investments, the Company has adopted procedures for the allocation of cash and investments, taking into consideration the credit limits and credit analysis of financial institutions, avoiding credit concentration, i.e. the credit risk is monitored and minimized by restricting negotiations to a select group of highly rated counterparties.

     

    22.4.3 Liquidity risk

     

    Historically, the Company’s primary sources of cash flow have been cash flow from operating activities, the issuance of debt, bank borrowing, and equity securities. Ambev’s material cash requirements have included the following: payments of dividends and interest on capital; capital expenditure; investments in companies; increases in the ownership of Ambev’s subsidiaries or in companies in which it holds equity investments; share buyback programs; and debt servicing.

     

    The Company believes that its cash flow from operating activities, cash and cash equivalents and short-term investments, together with derivatives and access to loan facilities are sufficient to finance its capital expenditure, financial liabilities, and dividend payments in the future.

     

                  06/30/2025
      Carrying amount Contractual cash flow Less than 1 year 1-2 years 2-3 years 3-5 years More than 5 years
    Trade and other payables (i) 31,908,553  33,714,494  30,561,762  105,948  28,604  1,155,469  1,862,711 
    Secured bank loans 102,429  131,397  30,671  25,182  25,181  50,363  -   
    Other secured loans 371,339  481,625  166,659  157,495  97,692  5,939  53,840 
    Lease liabilities  2,683,996  3,192,545  1,105,879  960,272  560,222  362,463  203,709 
      35,066,317  37,520,061  31,864,971  1,248,897  711,699  1,574,234  2,120,260 

     

                  12/31/2024
      Carrying amount Contractual cash flows Less than 1 year 1-2 years 2-3 years 3-5 years More than 5 years
    Trade and other payables (i) 41,771,683  43,322,074  40,229,728  101,188  (30,267) 1,200,759  1,820,666 
    Secured bank loans 115,421  154,869  28,961  25,181  25,182  50,364  25,181 
    Other secured loans 372,239  502,104  160,474  147,555  125,823  14,404  53,848 
    Lease liabilities  2,965,068  3,470,163  1,319,846  1,003,668  569,066  347,996  229,587 
      45,224,411  47,449,210  41,739,009  1,277,592  689,804  1,613,523  2,129,282 

     

    (i) Mainly includes amounts related to suppliers, taxes, fees and contributions payables, dividends and interest on equity payable, salaries and charges, put options related to the Company’s participation in subsidiaries and other liabilities, except for transactions with related parties.

     

    22.4.4 Capital management

     

    The Company continuously evaluates and optimizes its capital structure in order to maximize shareholder value while maintaining the desired financial flexibility to execute its strategic projects. Besides the statutory minimum equity funding requirements applicable to the Company’s subsidiaries in different countries, the Company is not subject to any externally imposed capital requirements. When analyzing its capital structure, the Company uses the same debt ratings and capital classifications that are applied to the financial statements.

     

     

    AMBEV S.A.

     

     

    The company monitors its net debt in order to guarantee the continuity of its business in the long term.

     

        06/30/2025 12/31/2024
    Debt details      
    Interest-bearing loans and borrowing current and non-current   3,157,764  3,452,728 
    (-) Current investment securities   (1,120,553) (1,242,001)
    (-) Cash and cash equivalents   (16,404,025) (28,595,666)
    Net debt/(cash)   (14,366,814) (26,384,939)

     

    22.4.5 Foreign currency risk

     

    The Company is exposed to foreign currency risk on its borrowing, investments, purchases, dividends and/or interest expenses/income where these are denominated in a currency other than the functional currency of Group entity. The main derivative financial instruments used to manage foreign currency risk are futures contracts, swaps, options, non-deliverable forwards and full deliverable forwards.

     

    22.5 Offsetting financial assets and liabilities

     

    For financial assets and liabilities that are subject to settlement agreements on a net basis or similar agreements, each agreement between the Company and the counterparty allows this type of settlement when both parties opt for this. In the absence of such a decision, the assets and liabilities will be settled at their gross amounts, but each party will have the option to settle on a net basis, in the case of default by the counterparty.

     

    22.6 Risk management in relation to climate change and the sustainability strategy

     

    Considering the nature of the Company’s operations, they are inherently exposed to certain risks related to climate change, and relevant sustainability aspects.

     

    There have been no changes in the key risks considered by management compared to those presented in the financial statements for the year ended December 31, 2024.

     

    23.COLLATERAL AND CONTRACTUAL COMMITMENTS TO SUPPLIERS, ADVANCES FROM CUSTOMERS AND OTHERS

     

      06/30/2025 12/31/2024
         
    Collateral given for the Company’s own liabilities 798,138  566,504 
    Other commitments 974,858  1,275,788 
      1,772,996  1,842,292 
         
    Commitments to suppliers - Property, plant and equipment and Intangibles 905,940  691,745 
    Commitments to suppliers - Inventory 30,494,446  46,942,988 
      31,400,386  47,634,733 

     

    At June 30, 2025, the Company had R$798,138 (R$540,126 at December 31, 2024) of cash guarantees.

     

     

    AMBEV S.A.

     

     

    Most of the commitments balance relates to obligations to packaging suppliers. These commitments are primarily aimed at ensuring a secure long-term supply of the Company’s strategic inputs, as well as offering greater assurance to suppliers making long-term investments. The future contractual commitments are presented below:

     

      06/30/2025 12/31/2024
         
    Less than 1 year 13,190,096  21,354,771 
    Between 1 and 2 years 6,661,568  12,333,160 
    More than 2 years 11,548,722  13,946,802 
      31,400,386  47,634,733 

     

    The deposits in cash used as guarantees are presented within other assets. The amount of fixed assets pledged as collateral is not material.

     

    24.RELATED PARTIES

     

    The Company adopts corporate governance practices as recommended and/or required by the applicable laws. Under the Company’s bylaws, the Board of Directors is responsible for approving any transactions or agreements between the Company and/or any of its subsidiaries (except wholly owned subsidiaries), its directors and/or shareholders (including direct or indirect partners of the Company’s shareholders). The Company's Governance Committee is responsible for advising the Board of Directors on related parties transactions matters, among others.

     

    Management is prohibited from interfering in any transaction in which a conflict of interest with the Company’s interests exists, even if only in theory. This prohibition also applies to the decisions taken by other members of Management on the matter. When such conflict exists, members must inform Management of the conflict and ensure that their non-participation in the deliberation is recorded in the minutes of the Board of Directors or Executive Board meeting.

     

    24.1 Transactions with key Management members

     

    Key Management includes the Executive Board of Officers and the Board of Directors. In addition to short-term benefits (primarily salaries), key Management members are entitled to participate in share-based payment programs, as described in note 21 – Share-based payments.

     

    The total expenses related to the Company’s Management members are as follow:

     

      six-month period ended:   Three-month period ended:
      06/30/2025 06/30/2024   06/30/2025 06/30/2024
               
    Short-term benefits (i) 25,340  25,939    11,814  14,797 
    Share-based payments (ii) 64,100  47,988    33,870  24,981 
    Social security (iii) 3,030  8,822    1,514  7,170 
    Total key Management remuneration  92,470  82,749    47,198  46,948 

     

    (i) These mainly correspond to management salaries and variable compensation (including performance bonuses).

     

    (ii) Reflects expenses related to share options, deferred shares, restricted stocks and performance shares granted to Management.

     

    (iii) Represents to the social security charges ("INSS”) levied on the Management’s remuneration.

     

    Except for the abovementioned remuneration, the Company has no other type of transaction with Management members, nor does it have outstanding balances receivable from or payable to them in its balance sheet.

     

     

    AMBEV S.A.

     


    24.2 Transactions with the Company's shareholders:

     

    24.2.1 Medical, dental and other benefits

     

    Fundação Zerrenner is one of Ambev’s shareholders, holding 10.2% of its share capital. Fundação Zerrenner is also an independent legal entity whose main goal is to provide Ambev’s employees, both active and retired, with healthcare and dental assistance, support for technical and higher education courses, and facilities for assisting elderly people, either directly or through financial assistance agreements with other entities. At June 30, 2025, and December 31, 2024, the actuarial obligations related to the benefits provided directly by Fundação Zerrenner were fully funded by plan assets held for this purpose, which significantly exceeded the respective liabilities at these dates.

     

    Ambev recognizes the assets (prepaid expenses) of this plan to the extent of the economic benefits that are available to the Company, arising from reimbursements or reductions in future contributions.

     

    In the six-month period ended June 30, 2025, the expenses incurred and recorded by Fundação Zerrenner with third parties to provide these benefits amounted to R$185,184 (R$172,593 at June 30, 2024), of which R$164,799 and R$20,385 were related to active employees and retirees, respectively (R$156,441 and R$16,152 at June 30, 2024, respectively).

     

    24.2.2 Licensing agreement with AB InBev

     

    The Company has a licensing agreement with AB InBev and some of its subsidiaries, such as Group Modelo and Spaten-Franziskaner-Bräu GmbH to produce, bottle, import, promote, sell and distribute its main products in the territories in which the Group operates. Similarly, the Company also grants a license to AB InBev and some of its subsidiaries of the same rights related to their main products, such as Brahma®, in AB Inbev’s territories.

     

    In the six-month period ended June 30, 2025, the Group recorded R$31,593 (R$20,344 at June 30, 2024) and R$657,876 (R$458,348 at June 30, 2024) and as royalties income and expenses, respectively in its Consolidated results.

     

    24.3 Transactions with related parties

     

    The Group’s consolidated results includes R$466,979 from sales of products, provision of services and other income in the six-month period ended June 30, 2025 (R$415,928 in June 30, 2024). Regarding product purchases and other expenses, the Group recorded, in the same six-month period ended June 30, 2025, the amount to R$(1,456,769) (R$1,340,312 in June 30, 2024). Finally, the amount to R$(9,720) was also recorded by the Group as Net financial results in Transactions with related parties in the six-month period ended June 30, 2025 (R$990 on June 30, 2024). The Group's main transactions were recorded with the following companies Anheuser-Busch InBev N.V., Anheuser-Busch Packaging Group Inc., Anheuser-Busch Inbev USA LLC, Bavaria S.A., Cervecería Modelo de Mexico S. de R.L. de C.V., among other.

     

    AMBEV S.A.

     
    25.EVENTS AFTER THE REPORTING PERIOD

     

    25.1 Distribution of dividends

     

    In a meeting held on July 30, 2025, the Board of Directors approved the distribution of dividends in the amount of R$0.1283 per share of the Company, based on the balances available in the extraordinary balance sheet dated as of June 30, 2025, of which the amount corresponding to the profit recorded in the period from January 1st to June 30, 2025 will be allocated to the minimum mandatory dividends for the 2025 fiscal year, without income tax withholding, pursuant to applicable law. The aforementioned payment shall be made on October 06, 2025, considering the shareholding position of August 07, 2025, with respect to B3 S.A. - Brasil, Bolsa, Balcão, and August 11, 2025 with respect to the New York Stock Exchange - NYSE, without any monetary adjustment. Shares and ADRs shall be traded ex-dividends as from and including August 08, 2025.

     

     

     

     
     

    SIGNATURE



    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

     

    Date: August 1, 2025

         
      AMBEV S.A.
         
      By:  /s/ Guilherme Fleury de Figueiredo Ferraz Parolari
     

    Guilherme Fleury de Figueiredo Ferraz Parolari

    Chief Financial and Investor Relations Officer


    Get the next $ABEV alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ABEV

    DatePrice TargetRatingAnalyst
    8/1/2025Buy → Hold
    HSBC Securities
    4/22/2025Buy → Neutral
    UBS
    4/7/2025Equal-Weight → Underweight
    Morgan Stanley
    1/17/2025Buy → Neutral
    BofA Securities
    3/4/2024$3.50 → $3.00Overweight → Equal Weight
    Barclays
    3/1/2024Overweight → Neutral
    JP Morgan
    12/8/2023Underweight → Equal-Weight
    Morgan Stanley
    12/7/2023Buy
    Citigroup
    More analyst ratings

    $ABEV
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    AMBEV'S 2024 ANNUAL REPORT ON FORM 20-F AVAILABLE ON OUR WEBSITE

    SÃO PAULO, March 12, 2025 /PRNewswire/ -- Ambev S.A. ([B3: ABEV3, NYSE:ABEV) announces that the Company's annual report on Form 20-F for the year ended December 31, 2024 was filed with the U.S. Securities and Exchange Commission - SEC (www.sec.gov) on March 12, 2025 and is available on the Company's website (ri.ambev.com.br) and also on the Company's page on SEC's database (www.sec.gov/edgar/). ADR holders may receive a hard copy of the Company's complete audited financial statements contained in the Form 20-F free of charge, upon request. To access the full document, please access the following links: click here. Ambev S.A. Investor Relations DepartmentContact e-mail: [email protected]

    3/12/25 7:22:00 PM ET
    $ABEV
    Beverages (Production/Distribution)
    Consumer Staples

    AMBEV'S 2023 ANNUAL REPORT ON FORM 20-F AVAILABLE ON OUR WEBSITE

    SÃO PAULO, March 11, 2024 /PRNewswire/ -- Ambev S.A. ([B3: ABEV3, NYSE:ABEV) announces that the Company's annual report on Form 20-F for the year ended December 31, 2023 was filed with the U.S. Securities and Exchange Commission - SEC ("SEC") on March 11, 2024 and is available on the Company's website (ri.ambev.com.br) and also on the SEC (www.sec.gov/edgar/). ADR holders may receive a hard copy of the Company's complete audited financial statements contained in the Form 20-F free of charge, upon request. To access the full document, please access the following links: click here. Ambev S.A. Investor Relations DepartmentContact e-mail: [email protected] View original content:https://www

    3/11/24 6:57:00 PM ET
    $ABEV
    Beverages (Production/Distribution)
    Consumer Staples

    AMBEV'S 2022 ANNUAL REPORT ON FORM 20-F AVAILABLE ON OUR WEBSITE

    SÃO PAULO, March 17, 2023 /PRNewswire/ -- Ambev S.A. ([B3: ABEV3, NYSE:ABEV) announces that the Company's annual report on Form 20-F for the year ended December 31, 2022 was filed with the U.S. Securities and Exchange Commission - SEC (www.sec.gov) on March 17, 2023 and is available on the Company's website (ri.ambev.com.br) and also on the Company's page on SEC's database (www.sec.gov/edgar/). ADR holders may receive a hard copy of the Company's complete audited financial statements contained in the Form 20-F free of charge, upon request. To access the full document, please access the following links: click here. CONTACT: Ambev S.A.Investor Relations DepartmentContact e-mail: [email protected]

    3/17/23 5:48:00 PM ET
    $ABEV
    Beverages (Production/Distribution)
    Consumer Staples

    $ABEV
    SEC Filings

    View All

    SEC Form 6-K filed by Ambev S.A.

    6-K - AMBEV S.A. (0001565025) (Filer)

    8/8/25 5:05:16 PM ET
    $ABEV
    Beverages (Production/Distribution)
    Consumer Staples

    SEC Form 6-K filed by Ambev S.A.

    6-K - AMBEV S.A. (0001565025) (Filer)

    8/8/25 5:03:37 PM ET
    $ABEV
    Beverages (Production/Distribution)
    Consumer Staples

    SEC Form 6-K filed by Ambev S.A.

    6-K - AMBEV S.A. (0001565025) (Filer)

    8/1/25 5:01:23 PM ET
    $ABEV
    Beverages (Production/Distribution)
    Consumer Staples

    $ABEV
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    AmBev downgraded by HSBC Securities

    HSBC Securities downgraded AmBev from Buy to Hold

    8/1/25 8:25:35 AM ET
    $ABEV
    Beverages (Production/Distribution)
    Consumer Staples

    AmBev downgraded by UBS

    UBS downgraded AmBev from Buy to Neutral

    4/22/25 7:20:21 AM ET
    $ABEV
    Beverages (Production/Distribution)
    Consumer Staples

    AmBev downgraded by Morgan Stanley

    Morgan Stanley downgraded AmBev from Equal-Weight to Underweight

    4/7/25 9:34:01 AM ET
    $ABEV
    Beverages (Production/Distribution)
    Consumer Staples